Cyclic Peptides That Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms
Open accessAbstract
Cyclic peptide scaffolds are key components of signal transduction pathways in both prokaryotic and eukaryotic organisms since they act as chemical messengers that activate or inhibit specific cognate receptors. In prokaryotic organisms these peptides are utilized in non-essential pathways, such as quorum sensing, that are responsible for virulence and pathogenicity. In the more evolved eukaryotic systems, cyclic peptide hormones play a key role in the regulation of the overall function of multicellular organisms, mainly through the endocrine system. This review will highlight several prokaryote and eukaryote systems that use cyclic peptides as their primary signals and the potential associated with utilizing these scaffolds for the discovery of novel therapeutics for a wide range of diseases and illnesses.
AI snapshot
Written from the paper’s full text.
TL;DR
This review describes cyclic peptides as key chemical messengers in prokaryotic quorum sensing and eukaryotic endocrine signal transduction, and it highlights their therapeutic potential through structure-activity studies and synthetic analogs. It covers bacterial systems such as staphylococcus, enterococcus, clostridium, and lactobacillus, then discusses somatostatin, insulin, oxytocin, and vasopressin.
Key findings
- Cyclic peptides act as signals in bacterial quorum sensing and eukaryotic hormone pathways; examples include staphylococcal autoinducing peptides (AIPs), enterococcal GBAP, clostridial agr-like peptides, lactobacillus lam, and the hormones somatostatin, insulin, oxytocin, and vasopressin.
- In *S. aureus*, AIP analogs inhibit AgrC receptors with reported IC50 values: AIP-I D5A at 5, 8, 0.3, and 3 nM against AgrC-I, -II, -III, and -IV; tAIP-I D2A at 5, 5, 0.1, and 5 nM; AIP-III D4A at 485, 429, 50.6, and 34.9 pM; and tAIP-III D2A at 257, 900, 329, and 95.7 pM. Amide-bridged analogs maintained high receptor affinity while improving metabolic and hydrolytic stability and water solubility.
- In *E. faecalis*, reversed-alanine scanning produced the FsrC antagonist ZBzl-YAA5911 with an IC50 of 26.2 nM; it significantly reduced retinal damage in an aphakic rabbit endophthalmitis model by inhibiting gelatinase expression.
- Native eukaryotic cyclic peptide hormones have short half-lives (somatostatin 2–3 min; oxytocin 3–6 min; vasopressin 10–35 min; insulin monomer 4–6 min), while analogs extend duration (octreotide 2 h IV and long-acting release every 28 days; lanreotide every 7–14 days; carbetocin 85–100 min; desmopressin ~55 min; degludec >42 h); Merotocin showed an EC50 of 0.08 nM versus 2.3 nM for oxytocin.
Methods
- Narrative review of cyclic peptide signal transduction pathways across prokaryotes and eukaryotes, focusing on selected Gram-positive bacterial quorum-sensing systems and selected peptide hormones.
- Synthesizes published structure-activity relationship studies, receptor pharmacology, and therapeutic analog development; no systematic search strategy, inclusion criteria, or meta-analysis is described.
Limitations
- The paper does not state a limitations section.
- Evident from the text: this is a narrative review with selected examples rather than a systematic or exhaustive synthesis, and it reports no primary experimental data or formal quality assessment of included studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 317 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Cyclic peptides are used as chemical signals, or pheromones, in prokaryotic signal transduction systems.
“Cyclic peptides are used as chemical signals, or pheromones, in prokaryotic signal transduction systems.”
Quote in the paperSubstantial claim - Premisecitation
Peptides of 2 to 50 amino acids regulate processes in prokaryotes and multicellular organisms by initiating signal transduction through activation or inhibition of specific receptors.
“Peptides, biological molecules generally comprised of 2 to 50 amino acids, regulate a multitude of processes in simple prokaryote cells as well as complex multicellular organisms by acting as chemical messengers that initiate signal transduction pathways through the activation or inhibition of specific receptors.[1]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Pawson T Nash P Protein-protein interactions define specificity in signal transduction Genes Dev 2000 14 9 1027 1047 10809663
Not checked in the free run.
- Premisenone given
Cyclic peptide scaffolds act as chemical messengers that activate or inhibit specific cognate receptors in signal transduction pathways in both prokaryotic and eukaryotic organisms.
“Cyclic peptide scaffolds are key components of signal transduction pathways in both prokaryotic and eukaryotic organisms since they act as chemical messengers that activate or inhibit specific cognate receptors.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Modifications that restrict the conformational space of short peptides are required to convert them into optimal signal transduction mediators.
“Therefore, modifications that restrict their conformational space are required to convert these scaffolds into optimal signal transduction mediators.[2]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Roxin A Zheng G Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides Future Med Chem 2012 4 12 1601 1618 22917248
Not checked in the free run.
- Premisecitation
The agr locus is composed of two divergent operons under the control of promoters P2 and P3 that produce RNAII and RNAIII transcripts, respectively.
“The agr locus is composed of two divergent operons that are under the control of promoters, P2 and P3, that produce RNAII and RNAIII transcripts, respectively.[4, 25]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [25] Ji G Pei W Zhang L Qiu R Lin J Benito Y Lina G Novick RP Staphylococcus intermedius produces a functional agr autoinducing peptide containing a cyclic lactone J Bacteriol 2005 187 9 3139 3150 15838041 PMC1082806
Not checked in the free run.
- Premisecitation
The macrocycle part of AIP signals is critical in triggering QS in staphylococci as the linear counterparts were largely inactive in Staphylococcus aureus.
“The macrocycle part of the AIP signals was found to be critical in triggering QS in staphylococci as the linear counterparts were found to be largely inactive in Staphylococcus aureus.[4, 21, 32]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [21] Ji G Beavis R Novick RP Bacterial interference caused by autoinducing peptide variants Science 1997 276 5321 2027 2030 9197262
Not checked in the free run.
- cites [32] Otto M Süßmuth R Vuong C Jung G Götz F Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives FEBS Lett 1999 450 3 257 262 10359085
Not checked in the free run.
- Premisenone given
When the AIP signal reaches a sufficiently high concentration it binds to the transmembrane receptor AgrC to trigger a signal transduction cascade.
“When the AIP signal reaches a sufficiently high concentration it binds to the transmembrane receptor, AgrC, to trigger a signal transduction cascade.”
Quote in the paperNot a substantial claim - Premisecitation
The pathogenicity of staphylococci is regulated by the accessory gene regulator (agr) QS circuit that controls expression of surface proteins, immune evasion factors and virulence factors.
“The pathogenicity of staphylococci is regulated by the accessory gene regulator (agr) QS circuit that controls, among others, the expression of surface proteins, immune evasion factors and virulence factors.[4, 19, 23, 24, 27]”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [19] Peng H Novick R Kreiswirth B Kornblum J Schlievert P Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus J Bacteriol 1988 170 9 4365 4372 2457579 PMC211451
Not checked in the free run.
- cites [23] Lyon GJ Wright JS Christopoulos A Novick RP Muir TW Reversible and specific extracellular antagonism of receptor-histidine kinase signaling J Biol Chem 2002 277 8 6247 6253 11733525
Not checked in the free run.
- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- cites [27] Geisinger E George EA Muir TW Novick RP Identification of ligand specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing receptor J Biol Chem 2008 283 14 8930 8938 18222919 PMC2276371
Not checked in the free run.
- Premisenone given
AgrB is critical in maturation of the chemical signal in staphylococci by catalyzing cyclization of the AIP signal.
“AgrB is critical in the maturation of the chemical signal in staphylococci by catalyzing the cyclization of the AIP signal.”
Quote in the paperNot a substantial claim - Premisecitation
The P2 operon controls expression of four genes-AgrA, AgrB, AgrC, and AgrD-that constitute the four components of the agr QS circuit and regulate expression of RNAIII.
“The P2 operon controls the expression of four genes—AgrA, AgrB, AgrC, and AgrD—that constitute the four components of the agr QS circuit and regulate the expression of the effector molecule of the circuitry, RNAIII.[20]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Novick R Projan S Kornblum J Ross H Ji G Kreiswirth B Vandenesch F Moghazeh S The agr P2 operon: An autocatalytic sensory transduction system in Staphylococcus aureus Mol Gen Genet 1995 248 4 446 458 7565609
Not checked in the free run.
- Premisecitation
Most cross-group interactions in S. aureus are inhibitory, suggestive of competition mediated by agr interference between the S. aureus specificity groups.
“Interestingly, Novick and co-workers have found that most cross-group interactions are inhibitory, suggestive of competition, mediated by agr interference, between the S. aureus specificity groups.[21, 41]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [21] Ji G Beavis R Novick RP Bacterial interference caused by autoinducing peptide variants Science 1997 276 5321 2027 2030 9197262
Not checked in the free run.
- cites [41] Geisinger E Muir TW Novick RP Agr receptor mutants reveal distinct modes of inhibition by staphylococcal autoinducing peptides Proc Natl Acad Sci U S A 2009 106 4 1216 1221 19147840 PMC2633565
Not checked in the free run.
- Premisecitation
Several truncated AIP analogs bearing only the macrocyclic structural feature effectively inhibit AgrC receptors and thus the agr QS circuitry in all S. aureus specificity groups.
“Indeed, several truncated AIP analogs bearing only the macrocyclic structural feature were found to effectively inhibit the AgrC receptors and thus the agr QS circuitry in all S. aureus specificity groups.[24, 45, 56]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- cites [45] Tal-Gan Y Stacy DM Foegen MK Koenig DW Blackwell HE Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide J Am Chem Soc 2013 135 21 7869 7882 23647400
Not checked in the free run.
- cites [56] Tal-Gan Y Ivancic M Cornilescu G Yang T Blackwell HE Highly Stable, Amide-Bridged Autoinducing Peptide Analogues that Strongly Inhibit the AgrC Quorum Sensing Receptor in Staphylococcus aureus Angew Chem Int Ed Engl 2016 55 31 8913 8917 27276693 PMC4972187
Not checked in the free run.
- Premisecitation
AIP-I D5A, an AIP-I analog with a single Asp to Ala mutation in the macrocyclic region, competitively inhibits all four AgrC receptors at low nM concentrations (IC50 values of 5, 8, 0.3, and 3 nM against AgrC-I, -II, -III, and -IV respectively).
“The first pan-group AgrC inhibitor to be reported was an AIP-I analog bearing a single Asp to Ala mutation in the macrocyclic region, AIP-I D5A (Figure 3).[40] Using QS reporter strains of all four agr groups, this peptide was found to competitively inhibit all four AgrC receptors at low nM concentrations (IC50 values of 5, 8, 0.3, and 3 nM against AgrC-I, -II, -III, and -IV respectively).[24]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40] McDowell P Affas Z Reynolds C Holden MT Wood SJ Saint S Cockayne A Hill PJ Dodd CE Bycroft BW Chan WC Williams P Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus Mol Microbiol 2001 41 2 503 512 11489134
Not checked in the free run.
- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- Premisecitation
SAR studies of AIP-I, -II and -III signals identified similar activity trends and required structural features for AgrC activation and inhibition.
“Structure-activity relationship (SAR) studies of the AIP-I, -II and –III signals conducted by Williams and co-workers,[40, 48] Muir and Novick and co-workers,[18, 23, 24, 49–52] and Blackwell and co-workers,[45, 53–56] respectively, identified similar activity trends and required structural features for AgrC activation and inhibition.”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [40] McDowell P Affas Z Reynolds C Holden MT Wood SJ Saint S Cockayne A Hill PJ Dodd CE Bycroft BW Chan WC Williams P Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus Mol Microbiol 2001 41 2 503 512 11489134
Not checked in the free run.
- cites [48] Scott RJ Lian LY Muharram SH Cockayne A Wood SJ Bycroft BW Williams P Chan WC Side-chain-to-tail thiolactone peptide inhibitors of the staphylococcal quorum-sensing system Bioorg Med Chem Lett 2003 13 15 2449 2453 12852941
Not checked in the free run.
- cites [18] Mayville P Ji G Beavis R Yang H Goger M Novick RP Muir TW Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence Proc Natl Acad Sci U S A 1999 96 4 1218 1223 9990004 PMC15443
Not checked in the free run.
- cites [23] Lyon GJ Wright JS Christopoulos A Novick RP Muir TW Reversible and specific extracellular antagonism of receptor-histidine kinase signaling J Biol Chem 2002 277 8 6247 6253 11733525
Not checked in the free run.
- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- cites [49] Lyon GJ Mayville P Muir TW Novick RP Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC Proc Natl Acad Sci U S A 2000 97 24 13330 13335 11087872 PMC27224
Not checked in the free run.
- cites [50] Wright JS Lyon GJ George EA Muir TW Novick RP Hydrophobic interactions drive ligand-receptor recognition for activation and inhibition of staphylococcal quorum sensing Proc Natl Acad Sci U S A 2004 101 46 16168 16173 15528279 PMC528941
Not checked in the free run.
- cites [51] George EA Novick RP Muir TW Cyclic peptide inhibitors of staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis J Am Chem Soc 2008 130 14 4914 4924 18335939
Not checked in the free run.
- cites [52] Johnson JG Wang B Debelouchina GT Novick RP Muir TW Increasing AIP Macrocycle Size Reveals Key Features of agr Activation in Staphylococcus aureus ChemBioChem 2015 16 7 1093 1100 25801678 PMC4589298
Not checked in the free run.
- cites [45] Tal-Gan Y Stacy DM Foegen MK Koenig DW Blackwell HE Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide J Am Chem Soc 2013 135 21 7869 7882 23647400
Not checked in the free run.
- Premisecitation
Activation of the agr circuitry by the AIP signal triggers virulence factor production in S. aureus.
“Furthermore, activation of the agr circuitry by the AIP signal was found to trigger virulence factor production in S. aureus.[4]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- Premisecitation
Early studies revealed that virulence was heavily controlled by the agr locus since agr-null S. aureus mutants had reduced ability to secrete toxins and other exoproteins.
“More specifically, early studies revealed that virulence was heavily controlled by the agr locus since agr-null S. aureus mutants had reduced ability to secrete toxins and other exoproteins.[35–38]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [35] Björklind A Arvidson S Mutants of Staphylococcus aureus affected in the regulation of exoprotein synthesis FEMS Microbiol Lett 1980 7 3 203 206
Not checked in the free run.
- cites [36] Janzon L Löfdahl S Arvidson S Evidence for a coordinate transcriptional control of alpha-toxin and protein A synthesis in Staphylococcus aureus FEMS Microbiol Lett 1986 33 2–3 193 198
Not checked in the free run.
- cites [37] Janzon L Löfdahl S Arvidson S Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus Mol Gen Genet 1989 219 3 480 485 2622452
Not checked in the free run.
- cites [38] Recsei P Kreiswirth B O'reilly M Schlievert P Gruss A Novick R Regulation of exoprotein gene expression in Staphylococcus aureus by agr Mol Gen Genet 1986 202 1 58 61 3007938
Not checked in the free run.
- Premisenone given
AgrC and AgrA form a two-component signal transduction system consisting of a transmembrane histidine kinase receptor and a response regulator, respectively.
“AgrC and AgrA work together to form a two-component signal transduction system (TCSTS) consisting of a transmembrane histidine kinase receptor and a response regulator, respectively.”
Quote in the paperNot a substantial claim - Premisecitation
Truncated tAIP-I D2A, bearing the same Asp to Ala modification but lacking the exocyclic tail, exhibits similar inhibitory activity (IC50 values of 5, 5, 0.1, and 5 nM against AgrC-I, -II, -III, and -IV respectively).
“Since the macrocycle portion was found to be critical for initial AgrC binding, the truncated version of AIP-I D5A, tAIP-I D2A (Figure 3), bearing the same Asp to Ala modification but lacking the exocyclic tail was introduced and exhibited similar inhibitory activity (IC50 values of 5, 5, 0.1, and 5 nM against AgrC-I, -II, -III, and -IV respectively).[24]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- Premisecitation
The chemical signal used by S. aureus was identified as an octapeptide containing a thiolactone macrocyclic portion that is required for QS activation.
“The chemical signal was identified as an octapeptide containing a thiolactone macrocyclic portion that is required for QS activation in S. aureus.[4, 24]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- Premisecitation
These peptides inhibit hemolysin and TSST-1 production at similar concentrations to the IC50 values obtained from reporter strains.
“The researchers further assessed the ability of these peptides to attenuate virulence factor production and have shown that these peptides inhibit hemolysin and TSST-1 production at similar concentrations to the IC50 values obtained from the reporter strains.[45]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Tal-Gan Y Stacy DM Foegen MK Koenig DW Blackwell HE Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide J Am Chem Soc 2013 135 21 7869 7882 23647400
Not checked in the free run.
- Premisecitation
A non-native QS modulator acts as a potent S. epidermidis agr-I biofilm formation inhibitor (IC50 2.08 nM).
“By combining these observations, Blackwell and co-workers revealed several non-native QS modulators with one analog acting as a potent S. epidermidis agr-I biofilm formation inhibitor (IC50 2.08 nM) (Figure 4).[64]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] Yang T Tal-Gan Y Paharik AE Horswill AR Blackwell HE Structure-Function Analyses of a Staphylococcus epidermidis Autoinducing Peptide Reveals Motifs Critical for AgrC-type Receptor Modulation ACS Chem Biol 2016 11 7 1982 1991 27159024 PMC4946969
Not checked in the free run.
- Premisecitation
Tyr7, Phe8, and Ala5, in addition to the thioester linkage, were all critical for S. epidermidis AgrC-I recognition.
“Through alanine and D-amino acid substitution screening they determined that Tyr7, Phe8, and Ala5, in addition to the thioester linkage, were all critical for S. epidermidis AgrC-I recognition.[64]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] Yang T Tal-Gan Y Paharik AE Horswill AR Blackwell HE Structure-Function Analyses of a Staphylococcus epidermidis Autoinducing Peptide Reveals Motifs Critical for AgrC-type Receptor Modulation ACS Chem Biol 2016 11 7 1982 1991 27159024 PMC4946969
Not checked in the free run.
- Premisecitation
Phe7 and Trp10 were identified as critical residues for receptor binding, as substitution of these residues almost completely abolished any activity against the FsrC receptor.
“Specifically, Phe7 and Trp10 were identified as critical residues for receptor binding, as substitution of these residues almost completely abolished any activity against the FsrC receptor.[77]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
- Interpretationreasoning
Combined studies highlight the potential of targeting the agr QS circuit in S. aureus as a therapeutic strategy.
“Combined, these studies highlight the potential of targeting the agr QS circuit in S. aureus as a therapeutic strategy.”
Quote in the paperSubstantial claim - Premisecitation
The thioester linkage was critical for agonistic activity of S. epidermidis AIP-I.
“Modification of the AIP-I pheromone was first performed by Otto and co-workers (Figure 4), where it was discovered that the thioester linkage was critical for agonistic activity (2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Otto M Echner H Voelter W Götz F Pheromone Cross-Inhibition between Staphylococcus aureus and Staphylococcus epidermidis Infect Immun 2001 69 3 1957 1960 11179383 PMC98112
Not checked in the free run.
- Premisenone given
The fsr system possesses a regulatory locus comprised of four genes, FsrA, FsrB, FsrC, and FsrD, all of which possess analogous roles to their agr counterparts.
“The fsr system possesses a regulatory locus comprised of four different genes, FsrA, FsrB, FsrC, and FsrD, all of which possess analogous roles to their agr counterparts.”
Quote in the paperNot a substantial claim - Premisenone given
Among various enterococcal species responsible for hospital infections, a QS circuit responsible for regulation of virulence factors has only been characterized in E. faecalis.
“Among the various enterococcal species responsible for hospital infections, a QS circuit responsible for the regulation of virulence factors has only been characterized in E. faecalis.”
Quote in the paperNot a substantial claim - Premisecitation
The negatively charged π-electron cloud located on the aromatic rings of Trp10 is critical for agonistic activity of the peptide.
“Lastly, it was found that the negatively charged π-electron cloud located on the aromatic rings of Trp10 is critical for agonistic activity of the peptide.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
- Premisecitation
The fsr circuit possesses shared homology with the staphylococcal agr QS system.
“This QS circuit, dubbed the fsr circuit, possesses shared homology with the staphylococcal agr QS system.[72, 73]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [72] Sifri CD Mylonakis E Singh KV Qin X Garsin DA Murray BE Ausubel FM Calderwood SB Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice Infect Immun 2002 70 10 5647 5650 12228293 PMC128331
Not checked in the free run.
- cites [73] Hancock LE Perego M The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase J Bacteriol 2004 186 17 5629 5639 15317767 PMC516840
Not checked in the free run.
- Premisecitation
FsrD was found to be the GBAP propeptide, as decreased FsrD translation resulted in decreased production of GBAP.
“FsrD was found to be the GBAP propeptide, as decreased FsrD translation resulted in decreased production of GBAP.[75]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Nakayama J Chen S Oyama N Nishiguchi K Azab EA Tanaka E Kariyama R Sonomoto K Revised model for Enterococcus faecalis fsr quorum-sensing system: the small open reading frame fsrD encodes the gelatinase biosynthesis-activating pheromone propeptide corresponding to staphylococcal AgrD J Bacteriol 2006 188 23 8321 8326 16980448 PMC1698201
Not checked in the free run.
- Premisecitation
ZBzl-YAA5911 was tested in an aphakic rabbit endophthalmitis model and significantly reduced retinal damage by enterococcal endophthalmitis through inhibition of gelatinase expression.
“ZBzl-YAA5911 was further tested in an aphakic rabbit endophthalmitis model and was found to significantly reduce retinal damage by enterococcal endophthalmitis through the inhibition of gelatinase expression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Nakayama J Yokohata R Sato M Suzuki T Matsufuji T Nishiguchi K Kawai T Yamanaka Y Nagata K Tanokura M Sonomoto K Development of a peptide antagonist against fsr quorum sensing of Enterococcus faecalis ACS Chem Biol 2013 8 4 804 811 23362999
Not checked in the free run.
- Premisecitation
NMR analysis of the ring region showed that it is highly compact, taking on a hairpin-like fold.
“NMR analysis of the ring region showed that it is highly compact, taking on a hairpin-like fold.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
- Premisereasoning
FsrD is processed and cyclized by FsrB before being exported from the cell as the mature GBAP cyclic peptide.
“FsrD is processed and cyclized by FsrB before being exported from the cell as the mature GBAP cyclic peptide.”
Quote in the paperNot a substantial claim - Premisecitation
The thioester linkage and its three-amino acid tail were found to be required for activation of the AgrC-I receptor.
“The thioester linkage and its three-amino acid tail were found to be required for the activation of the AgrC-I receptor.[32]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Otto M Süßmuth R Vuong C Jung G Götz F Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives FEBS Lett 1999 450 3 257 262 10359085
Not checked in the free run.
- Premisecitation
The centerpiece of this QS system is GBAP, an 11-amino acid cyclic peptide possessing a lactone ring between the hydroxyl group of Ser3 and the α-carboxyl group at the carboxy-terminus.
“The centerpiece of this QS system is the gelatinase biosynthesis activating pheromone (GBAP), an 11-amino acid cyclic peptide possessing a lactone ring between the hydroxyl group of Ser3, and the α-carboxyl group found at the carboxy-terminus of the peptide (Figure 5).[74]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Nakayama J Cao Y Horii T Sakuda S Akkermans AD De Vos WM Nagasawa H Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis Mol Microbiol 2001 41 1 145 154 11454207
Not checked in the free run.
- Premisecitation
The AIP-I chemical signal used by the S. epidermidis QS circuit was identified as an octapeptide containing a thioester linkage between the central cysteine and the C-terminal carboxyl group.
“The chemical signal was identified as an octapeptide containing a thioester linkage between the central cysteine and the C-terminal carboxyl group (Figure 2).[60]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Otto M Süßmuth R Jung G Götz F Structure of the pheromone peptide of the Staphylococcus epidermidis agr system FEBS Lett 1998 424 1–2 89 94 9537521
Not checked in the free run.
- Premisecitation
In both clostridium species, the agonistic synthetic peptides were found to activate toxin production, sporulation, and granulose formation.
“In both clostridium species, the agonistic synthetic peptides (Figure 6) were found to activate toxin production, sporulation, and granulose formation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Ma M Li J McClane BA Structure-function analysis of peptide signaling in the Clostridium perfringens Agr-like quorum sensing system J Bacteriol 2015 197 10 1807 1818 25777675 PMC4402402
Not checked in the free run.
- Premisecitation
Among these is an agr-like QS system that makes use of a cyclic peptide signaling molecule.
“Among these is an agr-like QS system that makes use of a cyclic peptide signaling molecule.[85, 86]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [85] Vidal JE Ma M Saputo J Garcia J Uzal FA McClane BA Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685 Mol Microbiol 2012 83 1 179 194 22150719 PMC3285497
Not checked in the free run.
- cites [86] Lee AS Song KP LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile Biochem Biophys Res Commun 2005 335 3 659 666 16098481
Not checked in the free run.
- Premisecitation
Sequence alignment of the AgrDs along with several synthetic peptides provided generalized structural information about the native AIPs, including a proposed thiolactone-containing macrocyclic component.
“However, sequence alignment of the AgrDs along with several synthetic peptides (Figure 6) that were able to activate the QS circuitry in C. perfringens and C. acetobutylicum provided generalized structural information about the native AIPs, including a proposed thiolactone-containing macrocyclic component.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Ma M Li J McClane BA Structure-function analysis of peptide signaling in the Clostridium perfringens Agr-like quorum sensing system J Bacteriol 2015 197 10 1807 1818 25777675 PMC4402402
Not checked in the free run.
- Premisecitation
Of these three species, only C. acetobutylicum possesses AgrC and AgrA, the transmembrane histidine kinase receptor and response regulator of the agr QS circuit.
“Of these three species, only C. acetobutylicum possesses AgrC and AgrA, the transmembrane histidine kinase receptor and response regulator of the agr QS circuit, respectively.[88]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] Steiner E Scott J Minton NP Winzer K An agr quorum sensing system that regulates granulose formation and sporulation in Clostridium acetobutylicum Appl Environ Microbiol 2012 78 4 1113 1122 22179241 PMC3273008
Not checked in the free run.
- Interpretationreasoning
In prokaryotic systems cyclic peptide scaffolds are used to modulate various signal transduction pathways responsible for group behaviors including biofilm formation, virulence and pathogenicity.
“Thus far this review has demonstrated that in prokaryotic systems cyclic peptide scaffolds are used to modulate various signal transduction pathways that are responsible for a variety of group behaviors including biofilm formation, virulence and pathogenicity.”
Quote in the paperSubstantial claim - Premisecitation
Several clostridium species including Clostridium perfringens, Clostridium botulinin, and Clostridium acetobutylicum contain agr QS-associated genes analogous to those seen within staphylococci.
“Several clostridium species including Clostridium perfringens, Clostridium botulinin, and Clostridium acetobutylicum contain agr QS-associated genes analogous to those seen within staphylococci.[84, 85, 87–89]”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [84] Chen J McClane BA Role of the Agr-like quorum-sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795 Infect Immun 2012 80 9 3008 3017 22689820 PMC3418738
Not checked in the free run.
- cites [85] Vidal JE Ma M Saputo J Garcia J Uzal FA McClane BA Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685 Mol Microbiol 2012 83 1 179 194 22150719 PMC3285497
Not checked in the free run.
- cites [87] Cooksley CM Davis IJ Winzer K Chan WC Peck MW Minton NP Regulation of neurotoxin production and sporulation by a putative agrBD signaling system in proteolytic Clostridium botulinum Appl Environ Microbiol 2010 76 13 4448 4460 20453132 PMC2897414
Not checked in the free run.
- cites [88] Steiner E Scott J Minton NP Winzer K An agr quorum sensing system that regulates granulose formation and sporulation in Clostridium acetobutylicum Appl Environ Microbiol 2012 78 4 1113 1122 22179241 PMC3273008
Not checked in the free run.
- cites [89] Ma M Li J McClane BA Structure-function analysis of peptide signaling in the Clostridium perfringens Agr-like quorum sensing system J Bacteriol 2015 197 10 1807 1818 25777675 PMC4402402
Not checked in the free run.
- Premisenone given
The lam system of L. plantarum is proposed to begin with synthesis of the AIP precursor peptide LamD, which undergoes processing by the LamB protein.
“The lam system of L. plantarum is proposed to begin with the synthesis of the AIP precursor peptide, LamD, which undergoes processing by the LamB protein.”
Quote in the paperNot a substantial claim - Premisecitation
Some species of lactobacillus use QS to enhance their ability to adapt to diverse environments and compete with other bacteria for various ecological niches.
“Some species of lactobacillus use QS to enhance their ability to adapt to diverse environments and compete with other bacteria for various ecological niches.[96, 97]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [96] Kleerebezem M Boekhorst J van Kranenburg R Molenaar D Kuipers OP Leer R Tarchini R Peters SA Sandbrink HM Fiers MW Stiekema W Lankhorst RM Bron PA Hoffer SM Groot MN Kerkhoven R de Vries M Ursing B de Vos WM Siezen RJ Complete genome sequence of Lactobacillus plantarum WCFS1 Proc Natl Acad Sci U S A 2003 100 4 1990 1995 12566566 PMC149946
Not checked in the free run.
- cites [97] Sturme MH Francke C Siezen RJ de Vos WM Kleerebezem M Making sense of quorum sensing in lactobacilli: a special focus on Lactobacillus plantarum WCFS1 Microbiology 2007 153 12 3939 3947 18048908
Not checked in the free run.
- Premisecitation
One of the synthetic peptides, peptide 6-R, was able to reduce or completely block toxin production in several different C. perfringens strains.
“More importantly, one of the synthetic peptides, peptide 6-R (Figure 6), was able to reduce or completely block toxin production in several different C. perfringens strains.[89]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Ma M Li J McClane BA Structure-function analysis of peptide signaling in the Clostridium perfringens Agr-like quorum sensing system J Bacteriol 2015 197 10 1807 1818 25777675 PMC4402402
Not checked in the free run.
- Premisenone given
Maturation of the chemical signal occurs when the AIP is cleaved from LamD to form a cyclic thiolactone peptide.
“Maturation of the chemical signal occurs when the AIP is cleaved from LamD to form a cyclic thiolactone peptide (Figure 7).”
Quote in the paperNot a substantial claim - Interpretationown data
These peptides can be modified to afford scaffolds with enhanced agonistic or antagonistic properties.
“Furthermore, it has been established that these peptides can be modified to afford scaffolds with enhanced agonistic or antagonistic properties.”
Quote in the paperNot a substantial claim - Premisecitation
LamA mutant strains had up-regulated biosynthesis of surface polysaccharides.
“Lastly, it was found that LamA mutant strains had up-regulated biosynthesis of surface polysaccharides.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] Sturme MH Nakayama J Molenaar D Murakami Y Kunugi R Fujii T Vaughan EE Kleerebezem M de Vos WM An agr-like two-component regulatory system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and regulation of adherence J Bacteriol 2005 187 15 5224 5235 16030216 PMC1196011
Not checked in the free run.
- Premisecitation
Several studies have highlighted the important role AgrB plays in toxin production and endospore formation of these clostridium species, revealing that a loss of AgrB significantly attenuates these aspects of clostridium pathogenesis.
“Several studies have highlighted the important role AgrB plays in toxin production and endospore formation of these clostridium species, revealing that a loss of AgrB significantly attenuates these aspects of clostridium pathogenesis.[87, 88, 92]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [87] Cooksley CM Davis IJ Winzer K Chan WC Peck MW Minton NP Regulation of neurotoxin production and sporulation by a putative agrBD signaling system in proteolytic Clostridium botulinum Appl Environ Microbiol 2010 76 13 4448 4460 20453132 PMC2897414
Not checked in the free run.
- cites [88] Steiner E Scott J Minton NP Winzer K An agr quorum sensing system that regulates granulose formation and sporulation in Clostridium acetobutylicum Appl Environ Microbiol 2012 78 4 1113 1122 22179241 PMC3273008
Not checked in the free run.
- cites [92] Li J Chen J Vidal JE McClane BA The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603 Infect Immun 2011 79 6 2451 2459 21464088 PMC3125842
Not checked in the free run.
- Premisecitation
Triggering the signaling cascade in L. plantarum by the AIP signal has been shown to affect transcription of a set of late-phase genes that include adhesins, surface polysaccharide biosynthesis, cell envelope and sugar utilization enzymes.
“Triggering the signaling cascade in L. plantarum by the AIP signal has been shown to affect the transcription of a set of late-phase genes that include adhesins, surface polysaccharide biosynthesis, cell envelope and sugar utilization enzymes.”
Quote in the paperNot a substantial claim - Premisecitation
To date, no confirmed structures of the cyclic peptides utilized by the clostridium agr QS circuits have been published.
“To date, no confirmed structures of the cyclic peptides utilized by the clostridium agr QS circuits have been published.[85, 88]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [85] Vidal JE Ma M Saputo J Garcia J Uzal FA McClane BA Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685 Mol Microbiol 2012 83 1 179 194 22150719 PMC3285497
Not checked in the free run.
- cites [88] Steiner E Scott J Minton NP Winzer K An agr quorum sensing system that regulates granulose formation and sporulation in Clostridium acetobutylicum Appl Environ Microbiol 2012 78 4 1113 1122 22179241 PMC3273008
Not checked in the free run.
- Premisecitation
The increased metabolic stability of cyclic peptides is attributed to the lower affinity of cyclic peptides to bind different peptidases.
“This increased metabolic stability is attributed to the lower affinity of cyclic peptides to bind different peptidases.[110–114]”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [110] Hess S Linde Y Ovadia O Safrai E Shalev DE Swed A Halbfinger E Lapidot T Winkler I Gabinet Y Faier A Yarden D Xiang Z Portillo FP Haskell-Luevano C Gilon C Hoffman A Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity J Med Chem 2008 51 4 1026 1034 18220330
Not checked in the free run.
- cites [111] Hess S Ovadia O Shalev DE Senderovich H Qadri B Yehezkel T Salitra Y Sheynis T Jelinek R Gilon C Hoffman A Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability J Med Chem 2007 50 24 6201 6211 17983214
Not checked in the free run.
- cites [112] Naveh S Tal-Gan Y Ling S Hoffman A Holoshitz J Gilon C Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads Bioorg Med Chem Lett 2012 22 1 493 496 22113111 PMC3580849
Not checked in the free run.
- cites [113] Young TS Young DD Ahmad I Louis JM Benkovic SJ Schultz PG Evolution of cyclic peptide protease inhibitors Proc Natl Acad Sci U S A 2011 108 27 11052 11056 21690365 PMC3131355
Not checked in the free run.
- cites [114] Lawson KV Rose TE Harran PG Template-constrained macrocyclic peptides prepared from native, unprotected precursors Proc Natl Acad Sci U S A 2013 110 40 E3753 E3760 24043790 PMC3791740
Not checked in the free run.
- Premisecitation
Cyclization of both bioactive somatostatin forms results from an intramolecular disulfide bridge formation that occurs prior to cleavage of the prohormone.
“Cyclization of both bioactive forms is the result of an intramolecular disulfide bridge formation that occurs prior to the cleavage of the prohormone.[119]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Patel YC O'Neil W Peptides derived from cleavage of prosomatostatin at carboxyl- and amino-terminal segments. Characterization of tissue and secreted forms in the rat J Biol Chem 1988 263 2 745 751 2891703
Not checked in the free run.
- Premisecitation
Peptide cyclization generally results in increased half-life compared to the linear peptide counterpart.
“From a pharmacological standpoint, peptide cyclization generally results in increased half-life compared to the linear peptide counterpart.[32]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Otto M Süßmuth R Vuong C Jung G Götz F Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives FEBS Lett 1999 450 3 257 262 10359085
Not checked in the free run.
- Premisereasoning
Many peptide hormones are constrained by peptide cyclization to achieve structural rigidity.
“To achieve such structural rigidity, many peptide hormones are constrained by peptide cyclization.”
Quote in the paperSubstantial claim - Premisecitation
Somatostatin has two biologically active isoforms that exist either as a 14-amino acid (SST-14) or 28-amino acid (SST-28) cyclic peptide hormone.
“Somatostatin was discovered in 1973 and has two biological active isoforms that exist either as a 14-amino acid (SST-14) or 28-amino acid (SST-28) cyclic peptide hormone (Figure 10).”
Quote in the paperNot a substantial claim - Premisecitation
Targets for polypeptide hormones are transmembrane receptors bearing a sensory domain located on the extracellular domain of the plasma membrane.
“The targets for the polypeptide hormones are thus transmembrane receptors bearing a sensory domain located on the extracellular domain of the plasma membrane.[109]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [109] Catt K Dufau M Peptide hormone receptors Annu Rev Physiol 1977 39 1 529 557 15500
Not checked in the free run.
- Premisecitation
Both bioactive isoforms of somatostatin can bind all five somatostatin receptor subtypes (SSTR1-5), although with varying affinities.
“Both bioactive isoforms of somatostatin can bind all five somatostatin receptor subtypes (SSTR1-5),[120] although with varying affinities.[123]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [120] Harris AG Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects Gut 1994 35 3 Suppl S1 S4 PMC1374387 7911441
Not checked in the free run.
- cites [123] Sun L Coy DH Somatostatin and its Analogs Curr Drug Targets 2016 17 5 529 537 26951062
Not checked in the free run.
- Interpretationreasoning
Peptide hormones should possess a relatively rigid structure that enables them to adopt only a small number of conformations.
“In the case of peptide hormones, this means the peptides should possess a relatively rigid structure that enables them to adopt only a small number of conformations.”
Quote in the paperSubstantial claim - Interpretationreasoning
These changes cause Glargine to microprecipitate in its hexameric form when injected as it moves from acidic pH to the physiological neutral pH of the blood, helping maintain basal insulin levels for 24 hours.
“Overall, these changes cause the molecule to microprecipitate in its hexameric form when injected, as it moves from acidic pH to the physiological neutral pH of the blood, helping maintain basal insulin levels for 24 hours.”
Quote in the paperSubstantial claim - Premisecitation
Oxytocin plays a significant role in drug addiction and withdrawal since it regulates the mesolimbic dopamine pathway.
“In addition to these functions, oxytocin plays a significant role in drug addiction and withdrawal since it regulates the mesolimbic dopamine pathway.[150]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] McGregor IS Bowen MT Breaking the loop: oxytocin as a potential treatment for drug addiction Horm Behav 2012 61 3 331 339 22198308
Not checked in the free run.
- Premisecitation
Clinical studies have shown no significant differences between all three rapid-acting analogs with regards to the time of onset.
“Clinical studies have shown no significant differences between all three rapid-acting analogs with regards to the time of onset.[134, 136]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [134] Homko C Deluzio A Jimenez C Kolaczynski JW Boden G Comparison of Insulin Aspart and Lispro Diabetes Care 2003 26 7 2027 2031 12832307
Not checked in the free run.
- cites [136] Garnock-Jones KP Plosker GL Insulin Glulisine Drugs 2009 69 8 1035 1057 19496630
Not checked in the free run.
- Premisecitation
Detemir has the exact same peptide sequence as native insulin, with the exception of a fatty acid (myristic acid) acylated to the epsilon-amino group of LysB29, and a deleted ThrB30 residue.
“Detemir has the exact same peptide sequence as native insulin, with the exception of a fatty acid (myristic acid) acylated to the epsilon-amino group of LysB29, and a deleted ThrB30 residue.[139, 140]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [139] Kurtzhals P Havelund S Jonassen I Kiehr B Larsen UD Ribel U Markussen J Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo Biochem J 1995 312 Pt 3 725 731 8554512 PMC1136174
Not checked in the free run.
- cites [140] Kurtzhals P Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir Int J Obes Relat Metab Disord 2004 28 Suppl 2 S23 28 15306834
Not checked in the free run.
- Premisecitation
Oxytocin has a short half-life of 3-6 minutes.
“Similar to somatostatin, oxytocin has a short half-life of 3–6 minutes.[155, 156]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [155] Fabian M Forsling ML Jones J Pryor J The clearance and antidiuretic potency of neurohypophysial hormones in man, their plasma binding and stability J Physiol 1969 204 3 653 5824107 PMC1351579
Not checked in the free run.
- cites [156] Welches WR Bridget Brosnihan K Ferrario CM A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11 Life Sci 1993 52 18 1461 1480 8387132
Not checked in the free run.
- Interpretationcitation
The conversion of the liable disulfide bond to a more stable C-S bond through incorporation of 1-butanoic acid at position 1, along with addition of the methoxy group on Tyr at position 2, are responsible for the longer half-life of Carbetocin compared with oxytocin.
“The conversion of the liable disulfide bond to a more stable C-S bond through the incorporation of 1-butanoic acid at position 1, along with the addition of the methoxy group on Tyr at position 2, are responsible for the longer half-life of Carbetocin compared with oxytocin.”
Quote in the paperNot a substantial claim - Premisereasoning
Several synthetic oxytocin analogs have been made that are longer lasting and more specific to the oxytocin receptor.
“To overcome the aforementioned problem, several synthetic analogs have been made that are longer lasting and more specific to the oxytocin receptor.”
Quote in the paperNot a substantial claim - Premisecitation
The cyclic nature of oxytocin was determined to provide the conformational constraint necessary for receptor specificity.
“The cyclic nature of oxytocin was determined to provide the conformational constraint necessary for receptor specificity.[146, 157]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [146] Gimpl G Fahrenholz F The Oxytocin Receptor System: Structure, Function, and Regulation Physiol Rev 2001 81 2 629 683 11274341
Not checked in the free run.
- cites [157] Gimpl G Reitz J Brauer S Trossen C Oxytocin receptors: ligand binding, signalling and cholesterol dependence Prog Brain Res 2008 170 193 204 18655883
Not checked in the free run.
- Premisecitation
NMR studies, along with analog assays, have provided a model for oxytocin:receptor binding where Ile3, Gln4, Pro7, and Leu8 are involved in initial receptor recognition while Tyr2 and Asn5 are involved in receptor and signaling pathway activation.
“NMR studies, along with analog assays, have provided a model for oxytocin:receptor binding where Ile3, Gln4, Pro7, and Leu8 are involved in the initial receptor recognition while Tyr2 and Asn5 are involved in receptor, and thus signaling pathway, activation.[158]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Wisniewski K Alagarsamy S Galyean R Tariga H Thompson D Ly B Wisniewska H Qi S Croston G Laporte R Riviere PJ Schteingart CD New, potent, and selective peptidic oxytocin receptor agonists J Med Chem 2014 57 12 5306 5317 24874785
Not checked in the free run.
- Premisecitation
The improved selectivity and enhanced binding affinity of Merotocin (EC50 value of 0.08 nM compared with 2.3 nM for oxytocin) are attributed to the replacement of Pro with N-4-fluorobenzyl glycine at position 7.
“The improved selectivity and enhanced binding affinity of Merotocin (EC50 value of 0.08 nM compared with 2.3 nM for oxytocin) are attributed to the replacement of Pro with N-4-fluorobenzyl glycine at position 7.[158]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [158] Wisniewski K Alagarsamy S Galyean R Tariga H Thompson D Ly B Wisniewska H Qi S Croston G Laporte R Riviere PJ Schteingart CD New, potent, and selective peptidic oxytocin receptor agonists J Med Chem 2014 57 12 5306 5317 24874785
Not checked in the free run.
- Premisecitation
A problem with using externally administered oxytocin during childbirth or lactation is that it can bind to the vasopressin subtype 2 (V2) receptor and cause antidiuresis, which can lead to hyponatremia.
“A problem with using externally administered oxytocin during childbirth or lactation is that it can bind to the vasopressin subtype 2 (V2) receptor and cause antidiuresis, which can lead to hyponatremia.[158]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Wisniewski K Alagarsamy S Galyean R Tariga H Thompson D Ly B Wisniewska H Qi S Croston G Laporte R Riviere PJ Schteingart CD New, potent, and selective peptidic oxytocin receptor agonists J Med Chem 2014 57 12 5306 5317 24874785
Not checked in the free run.
- Interpretationcitation
Felypressin therapeutic use is limited, except as a vasoconstrictor adjunct used with local anesthetics typically associated with dentistry, because of its selectivity to V1 receptors.
“Felypressin therapeutic use is limited, except as a vasoconstrictor adjunct used with local anesthetics typically associated with dentistry, because of its selectivity to V1 receptors.[179–181]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [179] Åkerman B On Felypressin (Octapressin®) as an Adjunct to Lidocaine and Prilocaine – an Experimental Study in Animals Acta Pharmacol Tox 1966 24 4 377 388 6013120
Not checked in the free run.
- cites [180] Inagawa M Ichinohe T Kaneko Y Felypressin, but not epinephrine, reduces myocardial oxygen tension after an injection of dental local anesthetic solution at routine doses J Oral Maxillofac Surg 2010 68 5 1013 1017 20031290
Not checked in the free run.
- cites [181] Cecanho R De Luca LA Jr Ranali J Anesth Prog Anesthesia progress 2006 53 4 119 125 17177590 PMC1705833
Not checked in the free run.
- Premisecitation
Desmopressin was later found to be effective for the treatment of bleeding disorders like hemophilia A and von Willebrand disease due to the V2 receptors involvement in osmoregulation and the production of blood clotting factors.
“However, it was later found to be effective for the treatment of bleeding disorders like hemophilia A and von Willebrand disease due to the V2 receptors involvement in osmoregulation and the production of blood clotting factors.[183, 184]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [183] Ślusarz MJ Ślusarz R Ciarkowski J Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist-bound state in the membrane–aqueous system Biopolymers 2006 81 5 321 338 16333859
Not checked in the free run.
- cites [184] Mannucci PM Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years Blood 1997 90 7 2515 2521 9326215
Not checked in the free run.
- Premisecitation
Synthetic analogs of vasopressin are being used therapeutically to treat septic shock, bedwetting, cardiac arrest, diabetes insipidus, von Willebrand disease and mild hemophilia A.
“Synthetic analogs of vasopressin are being used therapeutically to treat septic shock, bedwetting, cardiac arrest, diabetes insipidus, von Willebrand disease and mild hemophilia A.[174, 196–198]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [174] Sharman A Low J Vasopressin and its role in critical care Contin Educ Anaesth Crit Care Pain 2008 8 4 134 137
Not checked in the free run.
- cites [196] Evans JH Meadow SR Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response Arch Dis Child 1992 67 2 184 188 1543376 PMC1793412
Not checked in the free run.
- cites [197] Hodge EK Hughes DW Attridge RL Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock Ann Pharmacother 2016 (In press) 27340145
Not checked in the free run.
- cites [198] Miano TA Crouch MA Evolving Role of Vasopressin in the Treatment of Cardiac Arrest Pharmacotherapy 2006 26 6 828 839 16716136
Not checked in the free run.
- May combine two claims. 119
- Classified as probably not a substantial claim. 92
May combine two claims.
PremisereasoningShort peptide sequences are easier to transport but lack specificity and exhibit only moderate affinity to their target due to their ability to adopt a high number of conformations.
“On the other hand, short peptide sequences are easier to transport, but they lack specificity and only exhibit moderate affinity to their target due to their ability to adopt a high number of conformations.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenIn eukaryotic systems, cyclic peptide hormones play a key role in regulation of the overall function of multicellular organisms, mainly through the endocrine system.
“In the more evolved eukaryotic systems, cyclic peptide hormones play a key role in the regulation of the overall function of multicellular organisms, mainly through the endocrine system.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisereasoningPeptide cyclization is a widely used method of creating unique conformational constraints necessary for effective and specific receptor binding.
“Peptide cyclization is a widely used method of creating unique conformational constraints necessary for effective and specific receptor binding.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBiologically active cyclic peptides are naturally formed through diverse ring-closure methods including head-to-tail, side-chain-to-side-chain, head-to-side-chain, and side-chain-to-tail cyclization, and by utilizing various chemical bonds such as amide, lactone, thioester, or disulfide bonds.
“Biologically active cyclic peptides are naturally formed through diverse ring-closure methods, including head-to-tail, side-chain-to-side-chain, head-to-side-chain, and side-chain-to-tail cyclization, and by utilizing various chemical bonds such as amide, lactone, thioester, or disulfide bonds.[3]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Joo SH Cyclic peptides as therapeutic agents and biochemical tools Biomol Ther 2012 20 1 19 26 PMC3792197 24116270
Not checked in the free run.
May combine two claims.
PremisecitationMany genera of Gram-positive bacteria utilize cyclic peptides to assess their population density, and at high cell number synchronize to initiate group behavior phenotypes.
“In particular, many genera of Gram-positive bacteria utilize cyclic peptides to assess their population density, and at high cell number synchronize to initiate group behavior phenotypes.[4–6]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [5] Waters CM Bassler BL Quorum sensing: cell-to-cell communication in bacteria Annu Rev Cell Dev Biol 2005 21 319 346 16212498
Not checked in the free run.
- cites [6] Ng W-L Bassler BL Bacterial quorum-sensing network architectures Annu Rev Genet 2009 43 197 222 19686078 PMC4313539
Not checked in the free run.
May combine two claims.
PremisereasoningLarge peptide (15 to 50 amino acids) and protein (greater than 50 amino acids) scaffolds possess optimal pharmacological properties for signal transduction messengers because they form many contacts with their target receptor, leading to high affinity and specificity, while being efficiently inactivated and cleared.
“Large peptide, 15 to 50 amino acids, and protein, greater than 50 amino acids, scaffolds possess optimal pharmacological properties required for dynamic signal transduction messengers since they form a high number of contacts with their target receptor, leading to high affinity and specificity, while at the same time they are efficiently inactivated and cleared from the environment to prevent over”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe mature AIP is a short 7-12 amino acid peptide with a five-amino acid cyclic ring connected via a thiolactone bridge between the C-terminus of the peptide and a conserved cysteine (in Staphylococcus intermedius the AIP was identified as a lactone-containing signal).
“The mature AIP is a short 7–12 amino acid peptide with a five-amino acid cyclic ring connected via a thiolactone bridge between the C-terminus of the peptide and a conserved cysteine (in the case of Staphylococcus intermedius the AIP was identified as a lactone-containing signal, Figure 2).[4, 21, 25, 31]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [21] Ji G Beavis R Novick RP Bacterial interference caused by autoinducing peptide variants Science 1997 276 5321 2027 2030 9197262
Not checked in the free run.
- cites [25] Ji G Pei W Zhang L Qiu R Lin J Benito Y Lina G Novick RP Staphylococcus intermedius produces a functional agr autoinducing peptide containing a cyclic lactone J Bacteriol 2005 187 9 3139 3150 15838041 PMC1082806
Not checked in the free run.
- cites [31] Wang B Zhao A Novick RP Muir TW Key driving forces in the biosynthesis of autoinducing peptides required for staphylococcal virulence Proc Natl Acad Sci U S A 2015 112 34 10679 10684 26261307 PMC4553796
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPathogenic staphylococci species cause disease due to their ability to colonize within host tissues and secrete toxins that create damage and impair the host immune system.
“Pathogenic staphylococci species cause disease due to their ability to colonize within host tissues and secrete toxins that not only create damage, but also impair the host immune system.[22, 26]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [22] Lowy FD Staphylococcus aureus infections N Engl J Med 1998 339 8 520 532 9709046
Not checked in the free run.
- cites [26] Foster T Medical Microbiology 4 Baron S Galveston (TX) 1996
Not checked in the free run.
May combine two claims.
PremisecitationThe basic QS signaling mechanism consists of a synthase and a receptor; the synthase produces small signaling molecules secreted outside the cell, and upon reaching a threshold concentration they bind and activate the cognate receptor to trigger expression of group-related genes.
“The most basic of these signaling mechanisms consists of a synthase and a receptor. The synthase produces small signaling molecules that are secreted outside of the cell, and upon reaching a threshold concentration (corresponding to high bacterial density), the signaling molecules effectively bind and activate the cognate receptor to trigger the expression of genes involved in group-related”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [5] Waters CM Bassler BL Quorum sensing: cell-to-cell communication in bacteria Annu Rev Cell Dev Biol 2005 21 319 346 16212498
Not checked in the free run.
- cites [13] Gerdt JP Blackwell HE Competition studies confirm two major barriers that can preclude the spread of resistance to quorum-sensing inhibitors in bacteria ACS Chem Biol 2014 9 10 2291 2299 25105594 PMC4201345
Not checked in the free run.
- cites [14] Bassler BL How bacteria talk to each other: regulation of gene expression by quorum sensing Curr Opin Microbiol 1999 2 6 582 587 10607620
Not checked in the free run.
May combine two claims.
PremisecitationThe diversity of autoinducers allows specific bacterial species to assess their own cell density within a complex bacterial population and differentiate between other Gram-positive or Gram-negative species.
“The diversity of these autoinducers can thus allow specific bacterial species to assess their own cell density within a complex bacterial population and differentiate between other Gram-positive or Gram-negative species.[17]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Fuqua C Parsek MR Greenberg EP Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing Annu Rev Genet 2001 35 1 439 468 11700290
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMany species of staphylococci are opportunistic pathogens that cause infections such as skin infections, nosocomial infections of surgical wounds, food poisoning, toxic shock syndrome, urinary tract infections, and other serious ailments that may result in death if left untreated.
“However, many species of staphylococci are opportunistic pathogens that cause infections such as skin infections, nosocomial infections of surgical wounds, food poisoning, toxic shock syndrome (TSS), urinary tract infections, and other serious ailments that may result in death, if left untreated.[19, 26]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] Peng H Novick R Kreiswirth B Kornblum J Schlievert P Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus J Bacteriol 1988 170 9 4365 4372 2457579 PMC211451
Not checked in the free run.
- cites [26] Foster T Medical Microbiology 4 Baron S Galveston (TX) 1996
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAutoinducer 2 (AI-2), a furanosyl borate diester, is used by both Gram-negative and Gram-positive bacteria for interspecies signaling.
“Furthermore, autoinducer 2 (AI-2), a furanosyl borate diester, is used by both Gram-negative and Gram-positive bacteria for interspecies signaling.[6]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Ng W-L Bassler BL Bacterial quorum-sensing network architectures Annu Rev Genet 2009 43 197 222 19686078 PMC4313539
Not checked in the free run.
May combine two claims.
PremisecitationThe premature AIP is encoded by AgrD, which is proteolytically cleaved and secreted out of the cell by AgrB.
“The premature AIP is encoded by AgrD, which is proteolytically cleaved and secreted out of the cell by AgrB.[4, 25, 28–31]”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [25] Ji G Pei W Zhang L Qiu R Lin J Benito Y Lina G Novick RP Staphylococcus intermedius produces a functional agr autoinducing peptide containing a cyclic lactone J Bacteriol 2005 187 9 3139 3150 15838041 PMC1082806
Not checked in the free run.
- cites [28] Saenz HL Augsburger V Vuong C Jack RW Götz F Otto M Inducible expression and cellular location of AgrB, a protein involved in the maturation of the staphylococcal quorum-sensing pheromone Arch Microbiol 2000 174 6 452 455 11195102
Not checked in the free run.
- cites [29] Thoendel M Horswill AR Identification of Staphylococcus aureus AgrD residues required for autoinducing peptide biosynthesis J Biol Chem 2009 284 33 21828 21838 19520867 PMC2756194
Not checked in the free run.
- cites [30] Thoendel M Kavanaugh JS Flack CE Horswill AR Peptide signaling in the staphylococci Chem Rev 2011 111 1 117 151 21174435 PMC3086461
Not checked in the free run.
- cites [31] Wang B Zhao A Novick RP Muir TW Key driving forces in the biosynthesis of autoinducing peptides required for staphylococcal virulence Proc Natl Acad Sci U S A 2015 112 34 10679 10684 26261307 PMC4553796
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenGram-positive QS circuits generally consist of four components: the oligopeptide autoinducer, an endopeptidase, a transmembrane histidine kinase receptor, and a response regulator.
“Generally, the Gram-positive QS circuits consist of four different components, the oligopeptide autoinducer, an endopeptidase, a transmembrane histidine kinase receptor, and a response regulator.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere are two main classes of autoinducers that regulate QS: small signal molecules such as N-acyl-homoserine lactones (AHL), and oligopeptide autoinducers.
“There are two main classes of autoinducers that regulate QS: small signal molecules, such as N-acyl-homoserine lactones (AHL), and oligopeptide autoinducers.[6, 17]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [6] Ng W-L Bassler BL Bacterial quorum-sensing network architectures Annu Rev Genet 2009 43 197 222 19686078 PMC4313539
Not checked in the free run.
- cites [17] Fuqua C Parsek MR Greenberg EP Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing Annu Rev Genet 2001 35 1 439 468 11700290
Not checked in the free run.
May combine two claims.
PremisecitationAHL autoinducers bearing different fatty acid tails are utilized for intraspecies communication by Gram-negative bacteria, while oligopeptide autoinducers of varying sequences are utilized for intraspecies communication by Gram-positive bacteria.
“In general, AHL autoinducers bearing different fatty acid tails are utilized for intraspecies communication by Gram-negative bacteria, while oligopeptide autoinducers of varying sequences are utilized for intraspecies communication by Gram-positive bacteria.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Ng W-L Bassler BL Bacterial quorum-sensing network architectures Annu Rev Genet 2009 43 197 222 19686078 PMC4313539
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStaphylococci are the most studied Gram-positive genus that utilize QS to cause bacterial infections in their human hosts.
“Staphylococci are the most studied Gram-positive genus that utilize QS to cause bacterial infections in their human hosts.[4, 19–25]”
Quote in the paperNot a substantial claim0 of 8 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [19] Peng H Novick R Kreiswirth B Kornblum J Schlievert P Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus J Bacteriol 1988 170 9 4365 4372 2457579 PMC211451
Not checked in the free run.
- cites [20] Novick R Projan S Kornblum J Ross H Ji G Kreiswirth B Vandenesch F Moghazeh S The agr P2 operon: An autocatalytic sensory transduction system in Staphylococcus aureus Mol Gen Genet 1995 248 4 446 458 7565609
Not checked in the free run.
- cites [21] Ji G Beavis R Novick RP Bacterial interference caused by autoinducing peptide variants Science 1997 276 5321 2027 2030 9197262
Not checked in the free run.
- cites [22] Lowy FD Staphylococcus aureus infections N Engl J Med 1998 339 8 520 532 9709046
Not checked in the free run.
- cites [23] Lyon GJ Wright JS Christopoulos A Novick RP Muir TW Reversible and specific extracellular antagonism of receptor-histidine kinase signaling J Biol Chem 2002 277 8 6247 6253 11733525
Not checked in the free run.
- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- cites [25] Ji G Pei W Zhang L Qiu R Lin J Benito Y Lina G Novick RP Staphylococcus intermedius produces a functional agr autoinducing peptide containing a cyclic lactone J Bacteriol 2005 187 9 3139 3150 15838041 PMC1082806
Not checked in the free run.
May combine two claims.
PremisecitationThese group behaviors regulate symbiotic relationships with a bacterial host, such as bioluminescence and root nodulation, or coordinate bacterial pathogenicity including swarming, motility, competence, biofilm formation, and virulence factor production.
“These group behaviors regulate symbiotic relationships with a bacterial host, such as bioluminescence and root nodulation, or coordinate bacterial pathogenicity including swarming, motility, competence, biofilm formation, and virulence factor production.[7–9]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [7] Li Y-H Tian X Quorum sensing and bacterial social interactions in biofilms Sensors 2012 12 3 2519 2538 22736963 PMC3376616
Not checked in the free run.
- cites [8] Miller MB Bassler BL Quorum sensing in bacteria Annu Rev Microbiol 2001 55 1 165 199 11544353
Not checked in the free run.
- cites [9] Parsek MR Greenberg E Sociomicrobiology: the connections between quorum sensing and biofilms Trends Microbiol 2005 13 1 27 33 15639629
Not checked in the free run.
May combine two claims.
PremisecitationThe agr circuitry is conserved across staphylococci and is centered on a cyclic peptide signal (autoinducing peptide, AIP) that is secreted by the bacteria.
“The agr circuitry is conserved across staphylococci and is centered on a cyclic peptide signal (autoinducing peptide, AIP) that is secreted by the bacteria.[4, 21, 23, 24, 27]”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [21] Ji G Beavis R Novick RP Bacterial interference caused by autoinducing peptide variants Science 1997 276 5321 2027 2030 9197262
Not checked in the free run.
- cites [23] Lyon GJ Wright JS Christopoulos A Novick RP Muir TW Reversible and specific extracellular antagonism of receptor-histidine kinase signaling J Biol Chem 2002 277 8 6247 6253 11733525
Not checked in the free run.
- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
- cites [27] Geisinger E George EA Muir TW Novick RP Identification of ligand specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing receptor J Biol Chem 2008 283 14 8930 8938 18222919 PMC2276371
Not checked in the free run.
May combine two claims.
PremisecitationTruncated tAIP-II is a pan-group QS inhibitor with higher IC50 values (260, 230, 4, and 150 nM against AgrC-I, -II, -III, and -IV respectively).
“In addition, the truncated version of AIP-II, tAIP-II (Figure 3), was also found to be a pan-group QS inhibitor, although with higher IC50 values (IC50 values of 260, 230, 4, and 150 nM against AgrC-I, -II, -III, and -IV respectively).[24]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Lyon GJ Wright JS Muir TW Novick RP Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus Biochemistry 2002 41 31 10095 10104 12146974
Not checked in the free run.
May combine two claims.
PremisecitationReplacing the thioester linkage with an amide to afford lactam ring-containing analogs (AIP-III D4A Amide and tAIP-III D2A Amide) maintains high receptor affinities while enhancing pharmacological properties including metabolic and hydrolytic stability and water solubility.
“Lastly, they have also replaced the thioester linkage with an amide to afford a lactam ring-containing analogs, AIP-III D4A Amide and tAIP-III D2A Amide (Figure 3), and have shown that these analogs maintain their high receptor affinities while enhancing their pharmacological properties, including metabolic and hydrolytic stability as well as water solubility.[56]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Tal-Gan Y Ivancic M Cornilescu G Yang T Blackwell HE Highly Stable, Amide-Bridged Autoinducing Peptide Analogues that Strongly Inhibit the AgrC Quorum Sensing Receptor in Staphylococcus aureus Angew Chem Int Ed Engl 2016 55 31 8913 8917 27276693 PMC4972187
Not checked in the free run.
May combine two claims.
PremisecitationActivation of the TCSTS first upregulates RNAII transcription, resulting in autoinduction of the QS circuitry; later it activates the P3 promoter, leading to RNAIII transcription and expression of group behavior genes including hemolysins and exoproteins.
“The activation of the TCSTS first upregulates RNAII transcription, resulting in autoinduction of the QS circuitry necessary for behavioral change synchronization. At a later stage, the TCSTS also activates the P3 promoter, leading to RNAIII transcription and the expression of group behavior genes including hemolysins and exoproteins.[4, 25]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [25] Ji G Pei W Zhang L Qiu R Lin J Benito Y Lina G Novick RP Staphylococcus intermedius produces a functional agr autoinducing peptide containing a cyclic lactone J Bacteriol 2005 187 9 3139 3150 15838041 PMC1082806
Not checked in the free run.
May combine two claims.
PremisecitationThe agr system is activated during the post-exponential growth phase and is responsible for triggering staphylococcal pathogenesis.
“The agr system is activated during the post-exponential growth phase and is responsible for triggering staphylococcal pathogenesis.[4, 19]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Ji G Beavis RC Novick RP Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci U S A 1995 92 26 12055 12059 8618843 PMC40295
Not checked in the free run.
- cites [19] Peng H Novick R Kreiswirth B Kornblum J Schlievert P Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus J Bacteriol 1988 170 9 4365 4372 2457579 PMC211451
Not checked in the free run.
May combine two claims.
PremisecitationRemoval of the exocyclic tail in AIP-III D4A to form tAIP-III D2A does not reduce potency (IC50 values of 257, 900, 329, and 95.7 pM against AgrC-I, -II, -III, and -IV respectively), making these two analogs the most potent QS inhibitors known to date.
“In addition, they found that removal of the exocyclic tail in that analog to form tAIP-III D2A (Figure 3) does not reduce the potency of the peptide (IC50 values of 257, 900, 329, and 95.7 pM against AgrC-I, -II, -III, and -IV respectively), making these two peptide analogs the most potent QS inhibitors known to date.[45]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Tal-Gan Y Stacy DM Foegen MK Koenig DW Blackwell HE Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide J Am Chem Soc 2013 135 21 7869 7882 23647400
Not checked in the free run.
May combine two claims.
PremisecitationThe four agr groups strive in different niches and express different virulence factors, resulting in distinct disease profiles associated with each agr group.
“Moreover, the four groups were found to strive in different niches and express different virulence factors, resulting in distinct disease profiles associated with each agr group.”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [42] Jarraud S Mougel C Thioulouse J Lina G Meugnier H Forey F Nesme X Etienne J Vandenesch F Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (Alleles), and human disease Infect Immun 2002 70 2 631 641 11796592 PMC127674
Not checked in the free run.
- cites [43] Holtfreter S Grumann D Schmudde M Nguyen HTT Eichler P Strommenger B Kopron K Kolata J Giedrys-Kalemba S Steinmetz I Witte W Broker BM Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates J Clin Microbiol 2007 45 8 2669 2680 17537946 PMC1951235
Not checked in the free run.
- cites [44] Limbago B Fosheim GE Schoonover V Crane CE Nadle J Petit S Heltzel D Ray SM Harrison LH Lynfield R Dumyati G Townes JM Schaffner W Mu Y Fridkin SK Characterization of Methicillin-Resistant Staphylococcus aureus Isolates Collected in 2005 and 2006 from Patients with Invasive Disease: a Population-Based Analysis J Clin Microbiol 2009 47 5 1344 1351 19321725 PMC2681881
Not checked in the free run.
- cites [45] Tal-Gan Y Stacy DM Foegen MK Koenig DW Blackwell HE Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide J Am Chem Soc 2013 135 21 7869 7882 23647400
Not checked in the free run.
- cites [46] Goerke C Kümmel M Dietz K Wolz C Evaluation of intraspecies interference due to agr polymorphism in Staphylococcus aureus during infection and colonization J Infect Dis 2003 188 2 250 256 12854080
Not checked in the free run.
May combine two claims.
PremisecitationThree additional AIP signals were identified in S. aureus, leading to classification of four specificity groups within the species (agr-I through -IV).
“Soon after, three additional AIP signals were identified in S. aureus, leading to the classification of four specificity groups within the species (termed agr-I through -IV).[21, 39, 40]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [21] Ji G Beavis R Novick RP Bacterial interference caused by autoinducing peptide variants Science 1997 276 5321 2027 2030 9197262
Not checked in the free run.
- cites [39] Jarraud S Lyon G Figueiredo A Gérard L Vandenesch F Etienne J Muir T Novick R Exfoliatin-Producing Strains Define a Fourthagr Specificity Group in Staphylococcus aureus J Bacteriol 2000 182 22 6517 6522 11053400 PMC94802
Not checked in the free run.
- cites [40] McDowell P Affas Z Reynolds C Holden MT Wood SJ Saint S Cockayne A Hill PJ Dodd CE Bycroft BW Chan WC Williams P Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus Mol Microbiol 2001 41 2 503 512 11489134
Not checked in the free run.
May combine two claims.
PremisecitationThe macrocycle part of the AIP signal is involved in initial receptor recognition, while the exocyclic tail region is largely involved in receptor activation.
“These groups found that the macrocycle part of the AIP signal was involved in the initial receptor recognition, while the exocyclic tail region was largely involved in receptor activation.[50, 53, 55]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [50] Wright JS Lyon GJ George EA Muir TW Novick RP Hydrophobic interactions drive ligand-receptor recognition for activation and inhibition of staphylococcal quorum sensing Proc Natl Acad Sci U S A 2004 101 46 16168 16173 15528279 PMC528941
Not checked in the free run.
- cites [53] Tal-Gan Y Ivancic M Cornilescu G Cornilescu CC Blackwell HE Structural characterization of native autoinducing peptides and abiotic analogues reveals key features essential for activation and inhibition of an AgrC quorum sensing receptor in Staphylococcus aureus J Am Chem Soc 2013 135 49 18436 18444 24219181 PMC3887510
Not checked in the free run.
- cites [55] Tal-Gan Y Ivancic M Cornilescu G Blackwell HE Characterization of structural elements in native autoinducing peptides and non-native analogues that permit the differential modulation of AgrC-type quorum sensing receptors in Staphylococcus aureus Org Biomol Chem 2016 14 1 113 121 26416476 PMC4681674
Not checked in the free run.
May combine two claims.
PremisecitationGroups -I and -II are predominately found to cause invasive infections, Group -III is predominantly responsible for TSS, and group -IV is considered rare and is mainly involved in skin infections.
“Groups -I and -II are predominately found to cause invasive infections, Group -III is predominantly responsible for TSS, and group -IV is considered rare and is mainly involved in skin infections.[42–46]”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [42] Jarraud S Mougel C Thioulouse J Lina G Meugnier H Forey F Nesme X Etienne J Vandenesch F Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (Alleles), and human disease Infect Immun 2002 70 2 631 641 11796592 PMC127674
Not checked in the free run.
- cites [43] Holtfreter S Grumann D Schmudde M Nguyen HTT Eichler P Strommenger B Kopron K Kolata J Giedrys-Kalemba S Steinmetz I Witte W Broker BM Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates J Clin Microbiol 2007 45 8 2669 2680 17537946 PMC1951235
Not checked in the free run.
- cites [44] Limbago B Fosheim GE Schoonover V Crane CE Nadle J Petit S Heltzel D Ray SM Harrison LH Lynfield R Dumyati G Townes JM Schaffner W Mu Y Fridkin SK Characterization of Methicillin-Resistant Staphylococcus aureus Isolates Collected in 2005 and 2006 from Patients with Invasive Disease: a Population-Based Analysis J Clin Microbiol 2009 47 5 1344 1351 19321725 PMC2681881
Not checked in the free run.
- cites [45] Tal-Gan Y Stacy DM Foegen MK Koenig DW Blackwell HE Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide J Am Chem Soc 2013 135 21 7869 7882 23647400
Not checked in the free run.
- cites [46] Goerke C Kümmel M Dietz K Wolz C Evaluation of intraspecies interference due to agr polymorphism in Staphylococcus aureus during infection and colonization J Infect Dis 2003 188 2 250 256 12854080
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe agr QS circuitry has attracted significant attention as a potential anti-infective target for drug development.
“Thus, this QS circuitry has attracted significant attention as a potential anti-infective target for drug development.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThese specificity groups possess unique AIP signals, AgrC sensory domains and AgrB endopeptidases.
“These specific groups were found to possess unique AIP signals (Figure 2), AgrC sensory domains and AgrB endopeptidases.[30]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Thoendel M Kavanaugh JS Flack CE Horswill AR Peptide signaling in the staphylococci Chem Rev 2011 111 1 117 151 21174435 PMC3086461
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationS. epidermidis, while originally believed harmless, has been identified as one of the major causative agents of nosocomial infections.
“S. epidermidis, while originally believed to be harmless, has been identified as one of the major causative agents of nosocomial infections.[59]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Vuong C Otto M Staphylococcus epidermidis infections Microbes Infect 2002 4 4 481 489 11932199
Not checked in the free run.
May combine two claims.
PremisecitationThe ring size of GBAP can be adjusted without a loss of agonistic activity, and the carbonyl of the macrocycle linker is critical for agonistic activity.
“These experiments revealed that the ring size can be adjusted without a loss of agonistic activity, and that the carbonyl of the macrocycle linker is critical for agonistic activity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn a clinical setting, enterococci are responsible for a wide range of infections including endocarditis, bacteremia, urinary tract infections, and pelvic and intra-abdominal infections.
“In a clinical setting, enterococci are responsible for a wide range of infections including endocarditis, bacteremia, urinary tract infections, and pelvic and intra-abdominal infections.[67]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Sood S Malhotra M Das BK Kapil A Enterococcal infections & antimicrobial resistance Indian J Med Res 2008 128 2 111 121 19001673
Not checked in the free run.
May combine two claims.
PremisecitationVal3 was critical for activation of the S. epidermidis AgrC-I receptor, and Asp1 and Ser6 could be modified to have increased agonistic activity compared to the native peptide.
“Furthermore, they found that Val3 was critical for activation of the S. epidermidis AgrC-I receptor, and that Asp1 and Ser6 could be modified to have increased agonistic activity compared to the native peptide.[64]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] Yang T Tal-Gan Y Paharik AE Horswill AR Blackwell HE Structure-Function Analyses of a Staphylococcus epidermidis Autoinducing Peptide Reveals Motifs Critical for AgrC-type Receptor Modulation ACS Chem Biol 2016 11 7 1982 1991 27159024 PMC4946969
Not checked in the free run.
May combine two claims.
PremisecitationUpon reaching an extracellular threshold concentration, GBAP binds and activates FsrC, a transmembrane histidine kinase receptor that phosphorylates the response regulator FsrA to trigger the QS response.
“Upon reaching an extracellular threshold concentration, the GBAP binds and activates FsrC, a transmembrane histidine kinase receptor that phosphorylates the response regulator, FsrA, to trigger the QS response.[74, 76, 77]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [74] Nakayama J Cao Y Horii T Sakuda S Akkermans AD De Vos WM Nagasawa H Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis Mol Microbiol 2001 41 1 145 154 11454207
Not checked in the free run.
- cites [76] Nakayama J Cao Y Horii T Sakuda S Nagasawa H Chemical synthesis and biological activity of the gelatinase biosynthesis-activating pheromone of Enterococcus faecalis and its analogs Biosci Biotechnol Biochem 2001 65 10 2322 2325 11758932
Not checked in the free run.
- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
May combine two claims.
PremisecitationReversed-alanine scanning identified several novel peptides capable of FsrC inhibition, with the most potent analog being [Ala5,9,11]Z-GBAP.
“Using an N-terminal benzyloxycarbonyl protected receptor binding scaffold, several novel peptides capable of FsrC inhibition were identified, with the most potent analog being [Ala5,9,11]Z-GBAP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Nakayama J Yokohata R Sato M Suzuki T Matsufuji T Nishiguchi K Kawai T Yamanaka Y Nagata K Tanokura M Sonomoto K Development of a peptide antagonist against fsr quorum sensing of Enterococcus faecalis ACS Chem Biol 2013 8 4 804 811 23362999
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEnterococci are Gram-positive commensal bacteria known to inhabit soil or the alimentary canals of humans and animals.
“Enterococci are Gram-positive commensal bacteria, known to inhabit soil or the alimentary canals of humans and animals.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Arias CA Murray BE The rise of the Enterococcus: beyond vancomycin resistance Nat Rev Microbiol 2012 10 4 266 278 22421879 PMC3621121
Not checked in the free run.
May combine two claims.
PremisecitationThe Trp10 side chain contributes to both receptor binding and conformational stability of the cyclic peptide in its compact form.
“In addition, the Trp10 side chain was found to contribute to both receptor binding and conformational stability of the cyclic peptide in its compact form.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese infections are caused by a wide range of enterococcal virulence factors, including adhesins, hemolysins, gelatinases, and biofilm formation.
“These infections are caused by a wide range of enterococcal virulence factors, including adhesins, hemolysins, gelatinases, and biofilm formation.[68]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Coque TM Patterson JE Steckelberg JM Murray BE Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons J Infect Dis 1995 171 5 1223 1229 7751697
Not checked in the free run.
May combine two claims.
InterpretationcitationThis GBAP-mediated fsr QS system is responsible for regulation of many enterococcal virulence factors including gelatinase, serine protease, biofilm formation, and other extracellular proteases, making this system a key target for attenuation of E. faecalis virulence.
“This GBAP-mediated fsr QS system is responsible for the regulation of many enterococcal virulence factors including gelatinase, serine protease, biofilm formation, and other extracellular proteases, making this system a key target for the attenuation of E. faecalis virulence.[68]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Coque TM Patterson JE Steckelberg JM Murray BE Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons J Infect Dis 1995 171 5 1223 1229 7751697
Not checked in the free run.
May combine two claims.
InterpretationcitationThe Phe7 side chain faces outside of the cyclic ring and is likely directly involved in binding to the FsrC receptor.
“Combined, the biological assays and structural studies revealed that the Phe7 side chain was facing outside of the cyclic ring, and that this side chain is likely directly involved in binding to the FsrC receptor.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
May combine two claims.
PremisecitationTwo additional agr specificity groups were identified in S. epidermidis, and their AIPs were characterized as 12-amino acid peptides with a ring size equivalent to AIP-I.
“After the discovery of this first S. epidermidis AIP, two additional agr specificity groups were identified in S. epidermidis, and their AIPs were characterized.[61, 62] It was determined that both AIP-II and AIP-III were 12-amino acid peptides, with a ring size equivalent to AIP-I (Figure 2).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [61] Dufour P Jarraud S Vandenesch F Greenland T Novick RP Bes M Etienne J Lina G High genetic variability of the agr locus in Staphylococcus species J Bacteriol 2002 184 4 1180 1186 11807079 PMC134794
Not checked in the free run.
- cites [62] Olson ME Todd DA Schaeffer CR Paharik AE Van Dyke MJ Buttner H Dunman PM Rohde H Cech NB Fey PD Horswill AR Staphylococcus epidermidis agr quorum-sensing system: signal identification, cross talk, and importance in colonization J Bacteriol 2014 196 19 3482 3493 25070736 PMC4187671
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe rising trend in vancomycin resistance among enterococci, coupled with observed transfer of these antibiotic resistance genes to MRSA, makes enterococci a rapidly increasing threat in the clinical setting.
“The rising trend in vancomycin resistance among enterococci, coupled with the observed transfer of these antibiotic resistance genes to MRSA, makes enterococci a rapidly increasing threat in the clinical setting.[70, 71]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [70] Weigel LM Clewell DB Gill SR Clark NC McDougal LK Flannagan SE Kolonay JF Shetty J Killgore GE Tenover FC Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus Science 2003 302 5650 1569 1571 14645850
Not checked in the free run.
- cites [71] Cetinkaya Y Falk P Mayhall CG Vancomycin-resistant enterococci Clin Microbiol Rev 2000 13 4 686 707 11023964 PMC88957
Not checked in the free run.
May combine two claims.
PremisecitationAlanine scanning analysis determined that GBAP's entire ring region is involved in agonistic activity, while the tail region side chains are not strictly recognized.
“Through the alanine scanning, it was determined that GBAP’s entire ring region is involved in agonistic activity, while the tail region side chains are not strictly recognized.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMany species of enterococci, mainly Enterococcus faecalis and Enterococcus faecium, are opportunistic pathogens and enterococci as a genus are the third most commonly isolated nosocomial pathogen.
“Many species of enterococci, mainly Enterococcus faecalis and Enterococcus faecium, are opportunistic pathogens and enterococci as a genus are the third most commonly isolated nosocomial pathogen.[66]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Hollenbeck BL Rice LB Intrinsic and acquired resistance mechanisms in enterococcus Virulence 2012 3 5 421 569 23076243 PMC3485979
Not checked in the free run.
May combine two claims.
PremisecitationThe native S. epidermidis peptide was effective at inhibiting delta-toxin expression by S. aureus subgroups -I, -II, and -III, while it showed no effect on subgroup -IV.
“The native S. epidermidis peptide was found to be effective at inhibiting delta-toxin expression by S. aureus subgroups -I, -II, and -III, while it showed no effect on subgroup –IV.[63]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Otto M Echner H Voelter W Götz F Pheromone Cross-Inhibition between Staphylococcus aureus and Staphylococcus epidermidis Infect Immun 2001 69 3 1957 1960 11179383 PMC98112
Not checked in the free run.
May combine two claims.
PremisecitationInitial alanine scanning analysis of GBAP identified several peptides with lessened agonistic activity, but none exhibited antagonistic activity against FsrC.
“Overall, the initial alanine scanning analysis of GBAP identified several peptides with lessened agonistic activity, however, none exhibited antagonistic activity against FsrC.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] Nishiguchi K Nagata K Tanokura M Sonomoto K Nakayama J Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis J Bacteriol 2009 191 2 641 650 18996993 PMC2620804
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEnterococci have high levels of intrinsic and acquired resistance to many antibiotics, including acquired resistance to vancomycin.
“One of the most notable traits of enterococci is their high level of intrinsic and acquired resistance to many antibiotics. Among these is an acquired resistance to the last resort antibiotic, vancomycin, which is generally used to treat multi-drug resistant pathogens like Clostridium difficile and MRSA.[69]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Eliopoulos GM Gold H Vancomycin-resistant enterococci: mechanisms and clinical observations Clin Infect Dis 2001 33 2 210 219 11418881
Not checked in the free run.
May combine two claims.
InterpretationreasoningBiofilm formation in S. epidermidis is regulated by the agr QS circuit, presenting an opportunity to significantly attenuate S. epidermidis virulence by intercepting this circuitry.
“Biofilm formation in S. epidermidis is regulated by the agr QS circuit, presenting an opportunity to significantly attenuate S. epidermidis virulence by intercepting this circuitry.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitationagr interference occurred between groups -I and -II, and -I and -III, suggesting that these groups are in competition for the same niches and resources.
“It was determined that agr interference occurred between groups –I and –II, and –I and –III, suggesting that these groups are in competition for the same niches and resources.[62]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Olson ME Todd DA Schaeffer CR Paharik AE Van Dyke MJ Buttner H Dunman PM Rohde H Cech NB Fey PD Horswill AR Staphylococcus epidermidis agr quorum-sensing system: signal identification, cross talk, and importance in colonization J Bacteriol 2014 196 19 3482 3493 25070736 PMC4187671
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
InterpretationreasoningThe mutually symbiotic role of L. plantarum in the human body provides an opportunity to improve human health by activating the lam QS circuitry and thus promoting productive processes that can benefit the human host.
“Although not much is known about the lam QS circuit in L. plantarum, the mutually symbiotic role of this bacterium in the human body provides an opportunity to improve human health by activating the lam QS circuitry and thus promoting productive processes that can benefit the human host.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLamA-null L. plantarum strains exhibited significantly reduced adherence ability, and down regulation of sugar metabolism.
“Moreover, de Vos and co-workers reported that LamA-null L. plantarum strains exhibited significantly reduced adherence ability, and down regulation of sugar metabolism.[99]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] Sturme MH Nakayama J Molenaar D Murakami Y Kunugi R Fujii T Vaughan EE Kleerebezem M de Vos WM An agr-like two-component regulatory system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and regulation of adherence J Bacteriol 2005 187 15 5224 5235 16030216 PMC1196011
Not checked in the free run.
May combine two claims.
PremisecitationOne of these QS-TCSs is homologous to the staphylococcal agr and enterococci fsr QS circuits and has been identified as the Lactobacillus agr-like module (lam) with four genes: LamA, LamB, LamC, and LamD that play analogous role to their agr and fsr counterparts.
“One of these QS-TCSs is homologous to the staphylococcal agr and the enterococci fsr QS circuits and has been identified as the Lactobacillus agr-like module (lam) with four genes: LamA, LamB, LamC, and LamD that play analogous role to their agr and fsr counterparts.[99]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] Sturme MH Nakayama J Molenaar D Murakami Y Kunugi R Fujii T Vaughan EE Kleerebezem M de Vos WM An agr-like two-component regulatory system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and regulation of adherence J Bacteriol 2005 187 15 5224 5235 16030216 PMC1196011
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThese bacteria form a durable endospore to survive in oxygen-rich and high temperature environments, and are regarded among some of the most widely distributed pathogens in nature.
“These bacteria are known to form a durable endospore to survive in oxygen-rich and high temperature environments, and they are regarded among some of the most widely distributed pathogens in nature.[79, 80]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [79] Rood JI Cole ST Molecular genetics and pathogenesis of Clostridium perfringens Microbiol Rev 1991 55 4 621 648 1779929 PMC372840
Not checked in the free run.
- cites [80] Shimizu T Ohtani K Hirakawa H Ohshima K Yamashita A Shiba T Ogasawara N Hattori M Kuhara S Hayashi H Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater Proc Natl Acad Sci U S A 2002 99 2 996 1001 11792842 PMC117419
Not checked in the free run.
May combine two claims.
PremisereasoningLamC is the histidine kinase receptor and LamA acts as the cognate response regulator of this QS circuit.
“LamC is the histidine kinase receptor and LamA acts as the cognate response regulator of this QS circuit.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIt has been suggested that clostridium species like C. perfringens that lack the AgrC and AgrA components have the VirS/VirR two-component regulatory system, which has an analogous role to the AgrC/AgrA two-component system found within most agr-based QS circuits.
“It has been suggested that clostridium species like C. perfringens that lack the AgrC and AgrA components have the VirS/VirR two-component regulatory system, which has an analogous role to the AgrC/AgrA two-component system found within most agr-based QS circuits.[85, 90, 91]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [85] Vidal JE Ma M Saputo J Garcia J Uzal FA McClane BA Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685 Mol Microbiol 2012 83 1 179 194 22150719 PMC3285497
Not checked in the free run.
- cites [90] Vidal JE Chen J Li J McClane BA Use of an EZ-Tn 5-based random mutagenesis system to identify a novel toxin regulatory locus in Clostridium perfringens strain 13 PLoS One 2009 4 7 e6232 19597556 PMC2706048
Not checked in the free run.
- cites [91] Ohtani K Hirakawa H Tashiro K Yoshizawa S Kuhara S Shimizu T Identification of a two-component VirR/VirS regulon in Clostridium perfringens Anaerobe 2010 16 3 258 264 19835966
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn human infections, clostridium species are responsible for a wide range of diseases including gas gangrene, necrotizing enterocolitis, severe pseudomembranous colitis, and botulism.
“In human infections, clostridium species are responsible for a wide range of diseases including gas gangrene, necrotizing enterocolitis, severe pseudomembranous colitis, and botulism.[79, 81–83]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [79] Rood JI Cole ST Molecular genetics and pathogenesis of Clostridium perfringens Microbiol Rev 1991 55 4 621 648 1779929 PMC372840
Not checked in the free run.
- cites [81] Hambleton P Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use J Neurol 1992 239 1 16 20 1311751
Not checked in the free run.
- cites [82] Kelly CP LaMont JT Clostridium difficile infection Annu Rev Med 1998 49 375 390 9509270
Not checked in the free run.
- cites [83] Leffler DA Lamont JT Clostridium difficile infection N Engl J Med 2015 372 16 1539 1548 25875259
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationClostridium species are Gram-positive anaerobes commonly found in soil and sewage, but also known to inhabit the human gastrointestinal tract.
“Clostridium species are Gram-positive anaerobes that are commonly found in soil and sewage, but are also known to inhabit the human gastrointestinal tract.[79]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Rood JI Cole ST Molecular genetics and pathogenesis of Clostridium perfringens Microbiol Rev 1991 55 4 621 648 1779929 PMC372840
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecently, several different regulators of toxin production and endospore formation have been discovered in clostridium species.
“Recently, several different regulators of toxin production and endospore formation have been discovered in clostridium species.[84]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Chen J McClane BA Role of the Agr-like quorum-sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795 Infect Immun 2012 80 9 3008 3017 22689820 PMC3418738
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe ability to modulate many facets of clostridium pathogenesis using QS interference highlights the potential of cyclic peptide analogs that target non-essential pathways in clostridium species as therapeutic agents that are not likely to pressure the bacteria to develop resistance.
“The ability to modulate many facets of clostridium pathogenesis using QS interference highlights the potential of cyclic peptide analogs that target non-essential pathways in clostridium species as therapeutic agents that are not likely to pressure the bacteria to develop resistance.”
Quote in the paperNot a substantial claim- Rests on an assumption: Prokaryotic cyclic peptide signaling pathways, such as quorum sensing, are non-essential.
- Rests on an assumption: Therapeutic modulation of quorum sensing pathways is not likely to pressure bacteria to develop resistance.
May combine two claims.
PremisecitationLactobacillus plantarum naturally colonizes the human gastrointestinal tract and was found to possess multiple QS two-component regulatory systems that include a transmembrane histidine kinase and response regulator.
“One such species is Lactobacillus plantarum, a bacterium that naturally colonizes the human gastrointestinal tract, which was found to possess multiple QS two-component regulatory systems (QS-TCSs) that include a transmembrane histidine kinase and response regulator.[96–99]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [96] Kleerebezem M Boekhorst J van Kranenburg R Molenaar D Kuipers OP Leer R Tarchini R Peters SA Sandbrink HM Fiers MW Stiekema W Lankhorst RM Bron PA Hoffer SM Groot MN Kerkhoven R de Vries M Ursing B de Vos WM Siezen RJ Complete genome sequence of Lactobacillus plantarum WCFS1 Proc Natl Acad Sci U S A 2003 100 4 1990 1995 12566566 PMC149946
Not checked in the free run.
- cites [97] Sturme MH Francke C Siezen RJ de Vos WM Kleerebezem M Making sense of quorum sensing in lactobacilli: a special focus on Lactobacillus plantarum WCFS1 Microbiology 2007 153 12 3939 3947 18048908
Not checked in the free run.
- cites [98] Kleerebezem M Quadri LE Kuipers OP De Vos WM Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria Mol Microbiol 1997 24 5 895 904 9219998
Not checked in the free run.
- cites [99] Sturme MH Nakayama J Molenaar D Murakami Y Kunugi R Fujii T Vaughan EE Kleerebezem M de Vos WM An agr-like two-component regulatory system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and regulation of adherence J Bacteriol 2005 187 15 5224 5235 16030216 PMC1196011
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningTargeting the agr-based QS circuit, likely using cyclic peptide inhibitors derived from the native signaling peptide, could be utilized as a therapeutic pathway for treatment and prevention of clostridium-based infections.
“As sporulation and toxin production are important not only for clostridium pathogenesis, but also for their survival, targeting the agr-based QS circuit, likely using cyclic peptide inhibitors derived from the native signaling peptide, could be utilized as a therapeutic pathway for the treatment and prevention of clostridium-based infections.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationLactic acid bacteria are part of the genus Lactobacillus and are essential to the human gastrointestinal microflora, providing major health benefits by breaking down food and synthesizing essential vitamins.
“Lactic acid bacteria are part of the genus Lactobacillus and are essential to the human gastrointestinal microflora, providing major health benefits by breaking down food and synthesizing essential vitamins.[93–95]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [93] Vaughan EE de Vries MC Zoetendal EG Ben-Amor K Akkermans AD de Vos WM In Lactic Acid Bacteria: Genetics, Metabolism and Applications Springer 2002 341 352
Not checked in the free run.
- cites [94] Ouwehand AC Salminen S Isolauri E Probiotics: an overview of beneficial effects Antonie Van Leeuwenhoek 2002 82 1–4 279 289 12369194
Not checked in the free run.
- cites [95] Ahrné S Nobaek S Jeppsson B Adlerberth I Wold AE Molin G The normal Lactobacillus flora of healthy human rectal and oral mucosa J Appl Microbiol 1998 85 1 88 94 9721659
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere are three structural groups of hormones: fat or phospholipid derived hormones (eicosanoids and steroids), amino acid derived hormones (monoamine derivatives), and polypeptide derived hormones (peptides and protein).
“There are three structural groups of hormones: fat or phospholipid derived hormones (eicosanoids and steroids), amino acid derived hormones (monoamine derivatives), and polypeptide derived hormones (peptides and protein).[101]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Nussey SS Whitehead SA Endocrinology: an integrated approach CRC Press 2013 20821847
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenLanreotide is administered once every 7-14 days and is used to treat acromegaly in addition to helping ease symptoms of neuroendocrine tumors.
“A similar long-lasting FDA approved synthetic analog, Lanreotide, is administered once every 7–14 days and is used to treat acromegaly in addition to helping ease symptoms of neuroendocrine tumors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAccording to the signal hypothesis, polypeptides contain a signal sequence at the N-terminus that aids in transporting the protein or peptide to the rough endoplasmic reticulum through the translocon.
“According to the signal hypothesis proposed by Blobel and Sabatini, polypeptides contain a signal sequence at the N-terminus that aids in transporting the protein/peptide to the rough endoplasmic reticulum (ER) through the translocon.[104, 105]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [104] Johnson AE van Waes MA The translocon: a dynamic gateway at the ER membrane Annu Rev Cell Dev Biol 1999 15 1 799 842 10611978
Not checked in the free run.
- cites [105] Blobel G Sabatini DD Biomembranes Springer 1971 193 195
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe stability of different cyclic peptides can vary dramatically; oxytocin, vasopressin, and somatostatin have relatively short half-lives compared to insulin.
“That being said, the stability of different cyclic peptides can vary dramatically, for example oxytocin, vasopressin, and somatostatin have relatively short half-lives compared to insulin (Figure 9).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThese findings led to the development of the first FDA approved synthetic analog, Octreotide, which is used to treat acromegaly, various pituitary tumors, and pancreatic tumors by inhibiting the release of growth hormone, glucagon, and insulin.
“These findings led to the development of the first FDA approved synthetic analog, Octreotide, which is used to treat acromegaly, various pituitary tumors, and pancreatic tumors by inhibiting the release of growth hormone, glucagon, and insulin.[125]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [125] Lamberts SWJ Van der Lely A-J de Herder WW Hofland LJ Octreotide N Engl J Med 1996 334 4 246 254 8532003
Not checked in the free run.
May combine two claims.
PremisecitationThe signal peptide is cleaved by proteases in a co-translational step to transport the resulting prohormone to the ER, where it undergoes further processing including folding and cyclization.
“This signal peptide gets cleaved by proteases in a co-translational step to transport the resulting polypeptide (prohormone) to the ER, where it undergoes further processing, including proper folding and cyclization (Figure 8).[106, 107]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [106] Xu H Shields D Prohormone processing in the trans-Golgi network: endoproteolytic cleavage of prosomatostatin and formation of nascent secretory vesicles in permeabilized cells J Cell Biol 1993 122 6 1169 1184 8104189 PMC2119863
Not checked in the free run.
- cites [107] Perone M Castro M Prohormone and proneuropeptide synthesis and secretion Histol Histopathol 1997 12 4 1179 1188 9302577
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPeptide hormones are translated as nascent polypeptides called preprohormones that contain a signal peptide sequence.
“Peptide hormones are translated as nascent polypeptides called preprohormones that contain a signal peptide sequence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHormones are the chemical messengers that mediate various signal transduction pathways and regulate the overall functions of multicellular organisms.
“Hormones are the chemical messengers that mediate various signal transduction pathways and regulate the overall functions of multicellular organisms.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Berg JM Tymoczko JL Stryer L Biochemistry W.H. Freeman New York 2012
Not checked in the free run.
May combine two claims.
PremisecitationLys6 and Trp7 in SST-14 (20 and 21 in SST-28) are essential for bioactivity and incorporation of D-amino acids in these positions further stabilizes the beta turn.
“It was later determined that Lys6 and Trp7 in SST-14 (20 and 21 in SST-28) are essential for bioactivity and that the incorporation of D-amino acids in these positions further stabilizes the beta turn.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSomatostatin produced in the hypothalamus travels to the anterior pituitary gland where it inhibits release of growth hormone, prolactin, and thyroid stimulating hormone, while somatostatin from the gastrointestinal tract and pancreas inhibits secretion of calcitonin, gastrin, insulin, glucagon and vasoactive intestinal peptide.
“Somatostatin produced in the hypothalamus travels to the anterior pituitary gland where it inhibits the release of growth hormone, prolactin, and thyroid stimulating hormone, while somatostatin produced by the gastrointestinal tract and pancreas inhibits the secretion of various gastrointestinal hormones such as calcitonin, gastrin, insulin, glucagon and vasoactive intestinal peptide.[116, 117]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [116] Kumar U Grant M Cellular Peptide Hormone Synthesis and Secretory Pathways Rehfeld FJ Bundgaard RJ Springer Berlin Heidelberg Berlin, Heidelberg 2010 97 120
Not checked in the free run.
- cites [117] Ten Bokum A Hofland L van Hagen PM Somatostatin and somatostatin receptors in the immune system: a review Eur Cytokine Netw 2000 11 2 161 176 10903795
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese glands secrete various hormones into the bloodstream so that the hormones can reach their target tissues or organs in a timely manner.
“These glands secrete various hormones into the bloodstream so that the hormones can reach their target tissues or organs in a timely manner.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Nussey SS Whitehead SA Endocrinology: an integrated approach CRC Press 2013 20821847
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenPolypeptide derived hormones are the most abundant class of hormones, consisting of short to long polypeptide chains.
“Polypeptide derived hormones are the most abundant class of hormones consisting of short to long polypeptide chains.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome hormones, such as oxytocin, can operate under a positive feedback system where secretion increases in response to the hormone's presence.
“On the other hand, some hormones, such as oxytocin, can operate under a positive feedback system where the secretion of the hormone increases in response to the hormone’s presence.[102]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Russell JA Leng G Douglas AJ The magnocellular oxytocin system, the fount of maternity: adaptations in pregnancy Front Neuroendocrinol 2003 24 1 27 61 12609499
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSST-28 makes up about 20-30% of somatostatin in the brain and is mainly found in the gastrointestinal tract.
“SST-28 makes up about 20–30% of somatostatin in the brain and is mainly found in the gastrointestinal tract.[115]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] Patel YC Somatostatin and Its Receptor Family Front Neuroendocrinol 1999 20 3 157 198 10433861
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSomatostatin production starts as a 116-amino acid preprohormone, preprosomatostatin, that has its signal peptide cleaved prior to entering the ER to form the 92-amino acid prohormone, prosomatostatin.
“Somatostatin production starts as a 116-amino acid preprohormone, preprosomatostain, that has its signal peptide cleaved prior to entering the ER to form the 92-amino acid prohormone, prosomatostatin.[116, 117]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [116] Kumar U Grant M Cellular Peptide Hormone Synthesis and Secretory Pathways Rehfeld FJ Bundgaard RJ Springer Berlin Heidelberg Berlin, Heidelberg 2010 97 120
Not checked in the free run.
- cites [117] Ten Bokum A Hofland L van Hagen PM Somatostatin and somatostatin receptors in the immune system: a review Eur Cytokine Netw 2000 11 2 161 176 10903795
Not checked in the free run.
May combine two claims.
PremisecitationWater soluble peptide hormones act as primary messengers because they cannot cross the cell membrane, signaling target cells to initiate signal transduction cascades through intracellular secondary messengers.
“Water soluble peptide hormones act as primary messengers because they cannot cross the cell membrane, thus they signal the target cells to initiate signal transduction cascades through the production or absorption of intracellular secondary messengers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningAll hormones have relatively short half-lives because they have a dynamic role of activating and deactivating various signal transduction pathways.
“In general, all hormones have relatively short half-lives since they have a dynamic role of activating and deactivating various signal transduction pathways.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCertain hormones, such as estrogen, can induce a positive feedback system on other hormones.
“In some cases, certain hormones, such as estrogen, can induce a positive feedback system on other hormones.[103]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Wintermantel TM Campbell RE Porteous R Bock D Gröne H-J Todman MG Korach KS Greiner E Pérez CA Schütz G Herbison AE Definition of Estrogen Receptor Pathway Critical for Estrogen Positive Feedback to Gonadotropin-Releasing Hormone Neurons and Fertility Neuron 2006 52 2 271 280 17046690 PMC6116893
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenEicosanoid, polypeptide, and amino acid derived hormones have relatively short half-lives of seconds to minutes, while steroid hormones have moderately short half-lives of minutes to hours.
“Eicosanoids, polypeptide, and amino acid derived hormones have relatively short half-lives (seconds to minutes), while steroid hormones have moderately short half-lives (minutes to hours).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe use of somatostatin therapeutically is limited by its short half-life and has led to the development of analogs that are longer lasting.
“The use of somatostatin therapeutically is limited by its short half-life and has led to the development of analogs that are longer lasting.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSomatostatin is highly susceptible to endopeptidase degradation and thus has a short half-life of approximately 2-3 minutes.
“Somatostatin is highly susceptible to endopeptidase degradation and thus has a short half-life of approximately 2–3 minutes.[118, 124]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [118] Patel YC S Galanopoulou A Rabbani SN Liu J-L Ravazzola M Amherdt M Somatostatin-14, somatostatin-28, and prosomatostatin[1–10] are independently and efficiently processed from prosomatostatin in the constitutive secretory pathway in islet somatostatin tumor cells (1027B2)1 Mol Cell Endocrinol 1997 131 2 183 194 9296377
Not checked in the free run.
- cites [124] Mentlein R Dahms P Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes J Neurochem 1994 62 1 27 36 7903352
Not checked in the free run.
May combine two claims.
PremisecitationStructure-function relationship studies of somatostatin revealed that a beta turn formed by residues 7-10 in SST-14 (21-24 in SST-28) is required for receptor binding and that the disulfide bond creates a conformational constraint that stabilizes this conformation.
“Structure-function relationship studies of somatostatin revealed that a beta turn formed by residues 7–10 in SST-14 (21–24 in SST-28) is required for receptor binding and that the disulfide bond creates a conformational constraint that stabilizes this conformation.[123]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [123] Sun L Coy DH Somatostatin and its Analogs Curr Drug Targets 2016 17 5 529 537 26951062
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOctreotide has a longer half-life of 2 hours intravenously and also exists in a long-acting release form administered once every 28 days.
“Octreotide has a longer half-life of 2 hours intravenously and also exists in a long-acting release form administered once every 28 days.[125, 126]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [125] Lamberts SWJ Van der Lely A-J de Herder WW Hofland LJ Octreotide N Engl J Med 1996 334 4 246 254 8532003
Not checked in the free run.
- cites [126] McKeage K Cheer S Wagstaff AJ Octreotide Long-Acting Release (LAR) Drugs 2003 63 22 2473 2499 14609359
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenIn eukaryotic systems cyclic peptide scaffolds have a more essential role, regulating the overall function of multicellular organisms.
“In eukaryotic systems these cyclic peptide scaffolds have a more essential role, regulating the overall function of multicellular organisms.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisereasoningHormones must have high affinity and specificity to their particular receptors because they are secreted in low concentrations and should only activate their desired pathway.
“Hormones must have high affinity and specificity to their particular receptors because they are secreted in low concentrations and should only activate their desired pathway.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe dynamic functions and processes occurring in multicellular organisms require constant activation and deactivation of many signal transduction pathways.
“The dynamic functions and processes occurring in multicellular organisms require constant activation and deactivation of many signal transduction pathways.[100]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Berg JM Tymoczko JL Stryer L Biochemistry W.H. Freeman New York 2012
Not checked in the free run.
May combine two claims.
InterpretationcitationSomatostatin regulates, directly or indirectly, many functions in the body including cell growth, cell regeneration, and stomach acid production by binding five different somatostatin receptor subtypes (SSTR1-5).
“Therefore, somatostatin regulates, directly or indirectly, many functions in the body including cell growth, cell regeneration, and stomach acid production by binding five different somatostatin receptor subtypes (SSTR1-5).[115, 120–122]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [115] Patel YC Somatostatin and Its Receptor Family Front Neuroendocrinol 1999 20 3 157 198 10433861
Not checked in the free run.
- cites [120] Harris AG Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects Gut 1994 35 3 Suppl S1 S4 PMC1374387 7911441
Not checked in the free run.
- cites [121] Larsson L-I Goltermann N de Magistris L Rehfeld JF Schwartz TW Somatostatin Cell Processes as Pathways for Paracrine Secretion Science 1979 205 4413 1393 1395 382360
Not checked in the free run.
- cites [122] Rai U Thrimawithana TR Valery C Young SA Therapeutic uses of somatostatin and its analogues: Current view and potential applications Pharmacol Therapeut 2015 152 98 110 25956467
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenWithin eukaryotic systems, modifications of these peptides have been explored in order to increase their stability and potential therapeutic utility.
“Within eukaryotic systems, modifications of these peptides have been explored in order to increase their stability and potential therapeutic utility.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenMost hormones are under a negative feedback system to maintain homeostasis, where secretion decreases in response to activation of the hormone's signal transduction pathway.
“Most hormones are under a negative feedback system to maintain homeostasis where the secretion of hormones is decreased in response to activation of the hormone’s signal transduction pathway.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe majority of hormones produced in multicellular organisms are released into the bloodstream and are part of the endocrine system, which consists of the following hormone-producing glands: liver, pineal, pituitary, hypothalamus, parathyroid, testes, ovaries, adrenal and thymus.
“The majority of hormones produced in multicellular organisms are released into the bloodstream and are part of the endocrine system, which consists of the following hormone-producing glands: liver, pineal, pituitary, hypothalamus, parathyroid, testes, ovaries, adrenal and thymus.[101]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Nussey SS Whitehead SA Endocrinology: an integrated approach CRC Press 2013 20821847
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThree insulin dimers combine to form a hexamer by coordinating two zinc atoms with the imidazole groups of three His residues located at position B10, which gets packaged with other hexamers into insulin granules.
“Three dimers will combine to form a hexamer by coordinating two zinc atoms with the imidazole groups of three His residues located at position B10 that gets packaged with other hexamers into insulin granules.[131]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131] Fu Z Gilbert ER Liu D Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes Curr Diabetes Rev 2013 9 1 25 53 22974359 PMC3934755
Not checked in the free run.
May combine two claims.
PremisecitationDegludec is a new FDA approved ultrastable analog very similar to Detemir, having the same ThrB30 deletion but possessing a different fatty acid, hexadecanedioic acid, attached to the epsilon-amino group of LysB29 by a γ-L-glutamic acid linker.
“Recently, a new FDA approved ultrastable analog was released to the market: Degludec (Figure 11), which is very similar to Determir, having the same ThrB30 deletion but possessing a different fatty acid, hexadecanedioic acid, attached to the epsilon-amino group of LysB29 by a γ-L-glutamic acid linker.[143]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [143] Jonassen I Havelund S Hoeg-Jensen T Steensgaard DB Wahlund P-O Ribel U Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin Pharmaceut Res 2012 29 8 2104 2114 PMC3399081 22485010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationCurrent research regarding insulin analogs focuses on prolonging the bioactivity of the analogs, which would benefit diabetics by having them inject insulin less frequently.
“Current research regarding insulin analogs focuses on prolonging the bioactivity of the analogs, which would benefit diabetics by having them inject insulin less frequently.[135, 141, 142]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [135] Weiss M Design of ultra-stable insulin analogues for the developing world J Health Spec 2013 1 2 59 70
Not checked in the free run.
- cites [141] Atkin S Javed Z Fulcher G Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus Ther Adv Chronic Dis 2015 6 6 375 388 26568812 PMC4622316
Not checked in the free run.
- cites [142] Zinman B Newer insulin analogs: advances in basal insulin replacement Diabetes Obes Metab 2013 15 s1 6 10 23448197
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe social behaviors influenced by oxytocin include social bonding, depression, suppression of anxiety, and well-being, but it can also enhance fear and anxiety during negative or stressful experiences.
“The social behaviors influenced by oxytocin include social bonding, depression, suppression of anxiety, and well-being, but it can also enhance fear and anxiety during negative or stressful experiences.[151, 152]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [151] Churchland PS Winkielman P Modulating social behavior with oxytocin: How does it work? What does it mean? Horm Behav 2012 61 3 392 399 22197271 PMC3312973
Not checked in the free run.
- cites [152] Guzman YF Tronson NC Jovasevic V Sato K Guedea AL Mizukami H Nishimori K Radulovic J Fear-enhancing effects of septal oxytocin receptors Nat Neurosci 2013 16 9 1185 1187 23872596 PMC3758455
Not checked in the free run.
May combine two claims.
PremisecitationSeglitide selectively binds to SSTR2 and led to the development of various cyclohexapeptide analogs.
“This synthetic analog was found to selectively bind to SSTR2 and led to the development of various cyclohexapeptide analogs.[129]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Robertson CR Flynn SP White HS Bulaj G Anticonvulsant neuropeptides as drug leads for neurological diseases Nat Prod Rep 2011 28 4 741 762 21340067
Not checked in the free run.
May combine two claims.
PremisecitationProinsulin folds into a cyclic prohormone containing three disulfide bridges and is then cleaved by prohormone convertases and a carboxypeptidase, forming a monomeric cyclic peptide hormone.
“Proinsulin folds into a cyclic prohormone containing three disulfide bridges and is then cleaved by prohormone convertases and a carboxypeptidase, forming a monomeric cyclic peptide hormone.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131] Fu Z Gilbert ER Liu D Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes Curr Diabetes Rev 2013 9 1 25 53 22974359 PMC3934755
Not checked in the free run.
May combine two claims.
PremisecitationAspart is an FDA approved insulin analog where ProB28 was changed to Asp, creating a charge repulsion at the dimer interface, leading again to a rapid-acting insulin analog.
“For example, Aspart, another FDA approved insulin analog (Figure 11), is an insulin analog where ProB28 was changed to Asp creating a charge repulsion at the dimer interface, leading again to a rapid-acting insulin analog.[134, 135]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [134] Homko C Deluzio A Jimenez C Kolaczynski JW Boden G Comparison of Insulin Aspart and Lispro Diabetes Care 2003 26 7 2027 2031 12832307
Not checked in the free run.
- cites [135] Weiss M Design of ultra-stable insulin analogues for the developing world J Health Spec 2013 1 2 59 70
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOxytocin regulates many social and nonsocial functions in the body by binding to the oxytocin receptor located in the uterus and central nervous system.
“Oxytocin regulates many social and nonsocial functions in the body by binding to the oxytocin receptor located in the uterus and central nervous system.[146, 149]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [146] Gimpl G Fahrenholz F The Oxytocin Receptor System: Structure, Function, and Regulation Physiol Rev 2001 81 2 629 683 11274341
Not checked in the free run.
- cites [149] Yang H-P Wang L Han L Wang SC Nonsocial functions of hypothalamic oxytocin ISRN Neurosci 2013 2013 PMC4045544 24967304
Not checked in the free run.
May combine two claims.
PremisecitationThe active monomeric form of insulin binds to the insulin receptor located on the surface of cells and initiates a signal transduction cascade intracellularly that allows the entry of glucose into the cell.
“The active monomeric form binds to the insulin receptor located on the surface of cells and initiates a signal transduction cascade intracellularly that allows the entry of glucose into the cell.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenOxytocin has only one disulfide bridge while neurophysin I has seven.
“Oxytocin has only one disulfide-bridge while neurophysin I has seven.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThese oligomers prolong the dissociation of Degludec to the monomeric form, giving it a duration of action of more than 42 hours and allowing diabetic patients to inject it once every couple of days to help maintain basal insulin levels.
“These oligomers prolong the dissociation of the analogs to the monomeric form, giving it duration of action of more than 42 hours and allowing diabetic patients to inject it once every couple of days to help maintain basal insulin levels.[144]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [144] Haahr H Heise T A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance Clin Pharmacokinet 2014 53 9 787 800 25179915 PMC4156782
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAfrezza is the first FDA approved ultra-rapid-acting insulin preparation, consisting of powdered recombinant human insulin containing fumaryl diketopiperazine as an inert excipient.
“Researchers have also found an alternative method of delivering insulin in the form of inhalation, creating the first FDA approved ultra-rapid-acting insulin preparation, Afrezza.[145] Afrezza consists of powdered recombinant human insulin containing fumaryl diketopiperazine as an inert excipient.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [145] Klonoff DC Afrezza Inhaled Insulin: The Fastest-Acting FDA-Approved Insulin on the Market Has Favorable Properties J Diabetes Sci Technol 2014 8 6 1071 1073 25355710 PMC4455463
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenTherapeutic insulin and its analogs are mass produced using recombinant DNA technology for the treatment of diabetes mellitus.
“Therapeutic insulin and its analogs are mass produced using recombinant DNA technology for the treatment of diabetes mellitus.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBeta cells located in the islet of Langerhans of the pancreas produce a 110-amino acid pre-prohormone, preproinsulin, that is cleaved by signal peptidases into an 86-amino acid prohormone peptide, proinsulin.
“Beta cells located in the islet of Langerhans of the pancreas produce a 110-amino acid pre-prohormone, preproinsulin, that is cleaved by signal peptidases into an 86-amino acid prohormone peptide, proinsulin.[131]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131] Fu Z Gilbert ER Liu D Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes Curr Diabetes Rev 2013 9 1 25 53 22974359 PMC3934755
Not checked in the free run.
May combine two claims.
PremisecitationThe addition of the two Arg residues shifted the pI of Glargine from 5.4 to 6.7, making it more soluble in acidic conditions and less soluble at physiological pH.
“The addition of the two Arg residues shifted the pI of the molecule from 5.4 to 6.7 making it more soluble in acidic conditions and less soluble at physiological pH.[137]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Bolli BG Di Marchi DR Park DG Pramming S Koivisto AV Insulin analogues and their potential in the management of diabetes mellitus Diabetologia 1999 42 10 1151 1167 10525654
Not checked in the free run.
May combine two claims.
PremisecitationLispro is the first FDA approved insulin analog, almost identical to native insulin with amino acids ProB28 and LysB29 reversed; this modification decreases the dimerization rate resulting in a rapid-acting insulin analog.
“The first FDA approved insulin analog, Lispro (Figure 11), is almost identical to native insulin with amino acids ProB28 and LysB29 reversed. This modification decreases the dimerization rate resulting in a rapid-acting insulin analog.[133]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Holleman F Hoekstra JBL Insulin Lispro N Engl J Med 1997 337 3 176 183 9219705
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationResearch is currently pursuing thermostable insulin analogs, which would make insulin more available to third-world countries that do not have access to electricity and refrigeration.
“Another area of research that is currently being pursued involves creating thermostable analogs, which would make insulin more available to third-world countries that do not have access to electricity and refrigeration, a requirement for most insulin preparations currently used.[135]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] Weiss M Design of ultra-stable insulin analogues for the developing world J Health Spec 2013 1 2 59 70
Not checked in the free run.
May combine two claims.
PremisecitationGlargine is an insulin analog where AsnA21 was replaced with Gly and two Arg residues were added to the C-terminus of the B chain.
“Glargine is an insulin analog where the AsnA21 was replaced with Gly and two Arg residues were added to the C-terminus of the B chain.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPasireotide binds all SSTR subtypes except SSTR-4 and was FDA approved in 2012 to treat Cushing disease.
“Pasireotide binds all SSTR subtypes except SSTR-4 and was FDA approved in 2012 to treat Cushing disease.[123]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Sun L Coy DH Somatostatin and its Analogs Curr Drug Targets 2016 17 5 529 537 26951062
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationProoxytocin has a 93-amino acid carrier protein, neurophysin I, that gets cleaved from the prohormone and helps transport the mature oxytocin to the posterior pituitary gland where it gets secreted into the blood.
“Prooxytocin has a 93-amino acid carrier protein, neurophysin I, that gets cleaved from the prohormone and helps transport the mature oxytocin to the posterior pituitary gland where it gets secreted into the blood.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148] Richter D Molecular events in expression of vasopressin and oxytocin and their cognate receptors Am J Physiol 1988 255 2 Pt 2 F207 219 2841868
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMature insulin consists of two chains, the A chain (21 amino acids) and the B chain (30 amino acids), linked by two intermolecular disulfide bridges with an additional intramolecular disulfide bridge on the A chain.
“The mature insulin hormone consists of two chains: the A chain (21 amino acids) and the B chain (30 amino acids), which are linked by two intermolecular disulfide bridges with an additional intramolecular disulfide bridge present on the A chain.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOxytocin starts as a 121-amino acid precursor polypeptide, where the signal peptide gets cleaved during protein synthesis to form a 102-amino acid prohormone, prooxytocin.
“Oxytocin starts as a 121-amino acid precursor polypeptide, where the signal peptide gets cleaved during protein synthesis to form a 102-amino acid prohormone, prooxytocin.[148]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148] Richter D Molecular events in expression of vasopressin and oxytocin and their cognate receptors Am J Physiol 1988 255 2 Pt 2 F207 219 2841868
Not checked in the free run.
May combine two claims.
InterpretationcitationThe acidic environment of Glargine preparations makes it difficult to combine with other insulin analogs, so the development of a long-acting analog capable of being mixed with fast-acting analogs was needed.
“The acidic environment of Glargine preparations makes it difficult to combine with other insulin analogs, so the development of a long-acting analog capable of being mixed with fast-acting analogs was needed.[138]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [138] Vague P Selam J-L Skeie S De Leeuw I Elte JWF Haahr H Kristensen A Draeger E Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart Diabetes Care 2003 26 3 590 596 12610006
Not checked in the free run.
May combine two claims.
PremisereasoningThese modifications allow Detemir to bind to albumin in the blood, which causes it to dissociate slowly.
“These modifications allows Detemir to bind to albumin in the blood, which causes it to dissociate slowly.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLong-acting somatostatin analogs have been used to treat various diseases associated with dysregulation of growth hormone such as acromegaly, Cushing disease, and various neuroendocrine tumors.
“So far, long-acting somatostatin analogs have been used to treat various diseases associated with the dysregulation of growth hormone such as acromegaly, Cushing disease, and various neuroendocrine tumors.[122, 130]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [122] Rai U Thrimawithana TR Valery C Young SA Therapeutic uses of somatostatin and its analogues: Current view and potential applications Pharmacol Therapeut 2015 152 98 110 25956467
Not checked in the free run.
- cites [130] Shah P Rahman SA McElroy S Gilbert C Morgan K Hinchey L Senniappan S Levy H Amin R Hussain K Use of Long-Acting Somatostatin Analogue (Lanreotide) in an Adolescent with Diazoxide-Responsive Congenital Hyperinsulinism and Its Psychological Impact Horm Res Paediatr 2015 84 5 355 360 26375451
Not checked in the free run.
May combine two claims.
PremisereasoningGlulisine is a more recent FDA approved insulin analog that bears two amino acid modifications, AsnB3 to Lys and LysB29 to Glu, which alter the oligomerization equilibrium by decreasing formation of the hexameric form, allowing it to exist as a dimer at pharmacological concentrations.
“Another example is Glulisine, a more recent FDA approved insulin analog (Figure 11), that bears two amino acid modifications: AsnB3 to Lys, and LysB29 to Glu. These two modifications alter the oligomerization equilibrium by decreasing the formation of the hexameric form, allowing it to exist as a dimer at pharmacological concentrations.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe problem with native insulin and rapid-acting analogs is their relatively short half-lives, meaning patients with diabetes would have to receive multiple injections a day to regulate their blood glucose levels.
“The problem with native insulin and rapid-acting analogs is their relative short half-lives, meaning patients with diabetes would have to receive multiple injections a day to regulate their blood glucose levels.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningTightly controlled blood glucose levels are required for maintaining homeostasis, thus a combination of rapid-acting and long-lasting insulin analogs are needed to mimic the natural insulin secretion patterns in patients diagnosed with diabetes.
“Tightly controlled blood glucose levels are required for maintaining homeostasis, thus a combination of rapid-acting and long-lasting insulin analogs are needed to mimic the natural insulin secretion patterns in patients diagnosed with diabetes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOctreotide binds to SSTR2, SSTR5 and moderately to SSTR3 while Lanreotide binds to SSTR2 and SSTR5.
“Octreotide binds to SSTR2, SSTR5 and moderately to SSTR3 while Lanreotide binds to SSTR2 and SSTR5.[123, 125]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [123] Sun L Coy DH Somatostatin and its Analogs Curr Drug Targets 2016 17 5 529 537 26951062
Not checked in the free run.
- cites [125] Lamberts SWJ Van der Lely A-J de Herder WW Hofland LJ Octreotide N Engl J Med 1996 334 4 246 254 8532003
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNeurohypophysial hormones are secreted by the posterior pituitary gland and are all nine-amino acid peptides containing a disulfide bridge between positions 1 and 6 along with a three-amino acid tail that is α-amidated at the C-terminus.
“Neurohypophysial hormones refer to hormones secreted by the posterior pituitary (neurohypophysial) gland and are all nine-amino acid peptides containing a disulfide bridge between positons 1 and 6 along with a three-amino acid tail that is α-amidated at the C-terminus.[146, 147]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [146] Gimpl G Fahrenholz F The Oxytocin Receptor System: Structure, Function, and Regulation Physiol Rev 2001 81 2 629 683 11274341
Not checked in the free run.
- cites [147] Burbach JPH Luckman SM Murphy D Gainer H Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System Physiol Rev 2001 81 3 1197 1267 11427695
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHexameric insulin that is secreted into the bloodstream is cleared within an hour and the monomeric form has a half-life of 4-6 minutes.
“Hexameric insulin that is secreted into the bloodstream is cleared within an hour and the monomeric form has a half-life of 4–6 minutes.[132]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Duckworth WC Bennett RG Hamel FG Insulin degradation: progress and potential 1 Endocr Rev 1998 19 5 608 624 9793760
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe conformational constraint induced by cyclization was necessary rather than the disulfide bridge itself, leading to identification of the potent analog Seglitide.
“It was later determined that the conformational constraint induced by cyclization was necessary rather than the disulfide bridge itself, thus the potent analog, Seglitide, was identified.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe projected increase in diabetics provides the driving force to continuous efforts to develop novel insulin analogs that could better treat the growing diabetic population by closely mimicking natural homeostasis.
“The projected increase in diabetics provides the driving force to the continuous efforts to develop novel insulin analogs that could be applied to better treat the growing diabetic population by closely mimicking the natural homeostasis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenInsulin is a 51-amino acid peptide hormone responsible for regulating blood glucose levels by activating translocation of the glut4 symporter to the cell surface.
“Insulin is a 51-amino acid peptide hormone that is responsible for regulating blood glucose levels by activating the translocation of the glut4 symporter to the surface of the cell.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningThese modifications allow Degludec to exist as dihexamers in pharmacological preparations that form a linear array of hexamers (multihexamer) when injected.
“These modifications allows it to exist as dihexamers in pharmacological preparations that form a linear array of hexamers (multihexamer) when injected.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenThe nonsocial effects of oxytocin include learning, memory, brain development, organ development, aging, appetite, metabolism, and childbirth and lactation in females.
“The nonsocial effects of oxytocin include learning, memory, brain development, organ development, aging, appetite, metabolism, and childbirth and lactation in females.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
PremisereasoningThe benefit of Detemir is that it can be combined with other, rapid-acting insulin analogs.
“The benefit of Detemir is that it can be combined with other, rapid-acting insulin analogs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationVasopressin binds to the vasopressin receptor, which has three subtypes (V1-3) that differ in their distribution within the body.
“Vasopressin binds to the vasopressin receptor, which has three subtypes (V1-3) that differ in their distribution within the body.[172]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [172] Holmes CL Landry DW Granton JT Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology Crit Care 2003 7 6 427 434 14624682 PMC374366
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationUnlike oxytocin and Demoxytocin, Carbetocin is used to control postpartum hemorrhaging for both humans and animals in certain countries, not including the U.S.
“Unlike oxytocin and Demoxytocin, Carbetocin is used to control postpartum hemorrhaging for both humans and animals in certain countries, not including the U.S.[165, 166]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [165] Schramme AR Pinto CRF Davis J Whisnant CS Whitacre MD Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses Equine Vet J 2008 40 7 658 661 19165935
Not checked in the free run.
- cites [166] Borruto F Treisser A Comparetto C Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial Arch Gynecol Obstet 2009 280 5 707 712 19229549
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe potential to use oxytocin as a therapeutic agent is limited due to its short half-life, yet it is currently being used intravenously or intranasally to induce childbirth and lactation in women.
“The potential to use oxytocin as a therapeutic agent is limited due to its short half-life, yet it is currently being used intravenously or intranasally (longer half-life) to induce childbirth and lactation in women.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe benefit of Merotocin over oxytocin is that it is highly selective to the oxytocin receptor and does not interact with the V2 receptor.
“The benefit of Merotocin over oxytocin is that it is highly selective to the oxytocin receptor and does not interact with the V2 receptor.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Wisniewski K Alagarsamy S Galyean R Tariga H Thompson D Ly B Wisniewska H Qi S Croston G Laporte R Riviere PJ Schteingart CD New, potent, and selective peptidic oxytocin receptor agonists J Med Chem 2014 57 12 5306 5317 24874785
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationVasopressin differs from somatostatin and oxytocin by having a longer half-life of 10-35 minutes because it can only be cleared in the kidney and liver.
“Vasopressin differs from somatostatin and oxytocin by having a longer half-life of 10–35 minutes because it can only be cleared in the kidney and liver.[174]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Sharman A Low J Vasopressin and its role in critical care Contin Educ Anaesth Crit Care Pain 2008 8 4 134 137
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenThe benefit of Demoxytocin over oxytocin is that it can be delivered in a buccal tablet form instead of intravenously and is therefore commonly used in European countries.
“The benefit of Demoxytocin over oxytocin is that it can be delivered in a buccal tablet form instead of intravenously and is therefore commonly used in European countries.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDue to the relative similarity to vasopressin, oxytocin can bind the subtype 2 vasopressin receptor (V2) and induce antidiuresis, but with relatively low affinity.
“In addition, due to the relative similarity to vasopressin, oxytocin can bind the subtype 2 vasopressin receptor (V2) and induce antidiuresis, but with relatively low affinity.[153, 154]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [153] Terashima Y Kondo K Oiso Y Administration of oxytocin affects vasopressin V2 receptor and aquaporin-2 gene expression in the rat Life Sci 1999 64 16 1447 1453 10321724
Not checked in the free run.
- cites [154] Joo KW Jeon US Kim G-H Park J Oh YK Kim YS Ahn C Kim S Kim SY Lee JS Han JS Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2 Nephrol Dial Transpl 2004 19 10 2480 2486 15280526
Not checked in the free run.
May combine two claims.
PremisecitationMerotocin is a recent analog currently in clinical trials and shows great potential for inducing lactation in mothers that fail to lactate after preterm birth.
“A recent analog that is currently in clinical trials, Merotocin, shows great potential for inducing lactation in mothers that fail to lactate after preterm birth.[158]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Wisniewski K Alagarsamy S Galyean R Tariga H Thompson D Ly B Wisniewska H Qi S Croston G Laporte R Riviere PJ Schteingart CD New, potent, and selective peptidic oxytocin receptor agonists J Med Chem 2014 57 12 5306 5317 24874785
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationProvasopressin contains a 95-amino acid carrier protein (neurophysin II), vasopressin and a 39-amino acid glycosylated peptide (copeptin).
“Provasopressin contains a 95-amino acid carrier protein (neurophysin II), vasopressin and a 39-amino acid glycosylated peptide (copeptin).[173]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [173] Acher R Chauvet J Rouille Y Dynamic processing of neuropeptides J Mol Neurosci 2002 18 3 223 228 12059040
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationVasopressin is mainly known to regulate vasoconstriction, blood pressure, and water retention, but recently has been found to affect social behavior related to stress, memory, and anxiety.
“Vasopressin is mainly known to regulate vasoconstriction, blood pressure, and water retention, but recently has been found to affect social behavior related to stress, memory, and anxiety.[171, 172]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [171] Rotondo F Butz H Syro LV Yousef GM Di Ieva A Restrepo LM Quintanar-Stephano A Berczi I Kovacs K Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system Pituitary 2016 19 4 345 355 26762848
Not checked in the free run.
- cites [172] Holmes CL Landry DW Granton JT Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology Crit Care 2003 7 6 427 434 14624682 PMC374366
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOxytocin and its analogs are being investigated for their role in fighting drug addiction, social anxiety, social bonding, autism, and schizophrenia.
“Oxytocin and its analogs have many therapeutic uses related to childbirth and lactation, but it is also being investigated for its role in fighting drug addiction, social anxiety, social bonding, autism, and schizophrenia.[150, 151, 169, 170]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [150] McGregor IS Bowen MT Breaking the loop: oxytocin as a potential treatment for drug addiction Horm Behav 2012 61 3 331 339 22198308
Not checked in the free run.
- cites [151] Churchland PS Winkielman P Modulating social behavior with oxytocin: How does it work? What does it mean? Horm Behav 2012 61 3 392 399 22197271 PMC3312973
Not checked in the free run.
- cites [169] Anagnostou E Soorya L Brian J Dupuis A Mankad D Smile S Jacob S Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth Brain Res 2014 1580 188 198 24508578
Not checked in the free run.
- cites [170] Heringa SM Begemann MJ Goverde AJ Sommer IE Sex hormones and oxytocin augmentation strategies in schizophrenia: a quantitative review Schizophr Res 2015 168 3 603 613 25914107
Not checked in the free run.
May combine two claims.
PremisecitationCarbetocin has a similar binding profile as oxytocin and a longer half-life (85-100 minutes) than both oxytocin and Demoxytocin.
“Another synthetic analog, Carbetocin, has a similar binding profile as oxytocin and longer half-life (85–100 minutes) than both oxytocin and Demoxytocin.[163–165]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [163] Gimpl G Postina R Fahrenholz F Reinheimer T Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin Eur J Pharmacol 2005 510 1 9 16 15740719
Not checked in the free run.
- cites [164] Engstrøm T Barth T Melin P Vilhardt H Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation Eur J Pharmacol 1998 355 2 203 210 9760035
Not checked in the free run.
- cites [165] Schramme AR Pinto CRF Davis J Whisnant CS Whitacre MD Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses Equine Vet J 2008 40 7 658 661 19165935
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationVasopressin's role in water retention and blood pressure has made it a useful therapeutic for bleeding disorders, organ transplants, treating septic shock and cardiac arrest.
“Vasopressin’s role in water retention and blood pressure has made it a useful therapeutic for bleeding disorders, organ transplants, treating septic shock and cardiac arrest.[176]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [176] Mitchell SLM Hunter JM Vasopressin and its antagonists: what are their roles in acute medical care? Br J Anaesth 2007 99 2 154 158 17616565
Not checked in the free run.
May combine two claims.
InterpretationcitationThe relatively short half-life of vasopressin, like other peptide hormones, limits its therapeutic uses so the development of longer lasting analogs has been pursued.
“The relatively short half-life of vasopressin, like other peptide hormones, limits its therapeutic uses so the development of longer lasting analogs has been pursued.[174, 177, 178]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [174] Sharman A Low J Vasopressin and its role in critical care Contin Educ Anaesth Crit Care Pain 2008 8 4 134 137
Not checked in the free run.
- cites [177] Sawyer W Pang P Seto J McEnroe M Lammek B Manning M Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone Science 1981 212 4490 49 51 7209515
Not checked in the free run.
- cites [178] Manning M Misicka A Olma A Bankowski K Stoev S Chini B Durroux T Mouillac B Corbani M Guillon G Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics J Neuroendocrinol 2012 24 4 609 628 22375852 PMC3490377
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVasopressin is produced as a 162-amino acid preprohormone that becomes the 143-amino acid prohormone when the signal sequence is cleaved.
“The hormone is produced as a 162-amino acid preprohormone that becomes the 143-amino acid prohormone when the signal sequence is cleaved.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [173] Acher R Chauvet J Rouille Y Dynamic processing of neuropeptides J Mol Neurosci 2002 18 3 223 228 12059040
Not checked in the free run.
May combine two claims.
PremisecitationThe enhanced stability of Carbetocin is attributed to reduced rate of macrocycle ring opening and prevention of chymotrypsin degradation.
“This enhanced stability is attributed to reduced rate of macrocycle ring opening and prevention of chymotrypsin degradation, respectively.[167, 168]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [167] Morioka T Loik ND Hipolito CJ Goto Y Suga H Selection-based discovery of macrocyclic peptides for the next generation therapeutics Curr Opin Chem Biol 2015 26 34 41 25703142
Not checked in the free run.
- cites [168] Vilhardt H Atke A Barthova J Ubik K Barth T Interaction of chymotrypsin with carbetocin ([1-deamino-1-monocarba-2-O-methyltyrosine]-oxytocin) Pharmacol Toxicol 1997 81 3 147 150 9335073
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDemoxytocin is a synthetic analog with similar potency and half-life as oxytocin, created in the 1960s to induce labor.
“Demoxytocin, a synthetic analog with similar potency and half-life as oxytocin, was created in the 1960’s to induce labor.[159–162]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [159] Gazis D Roy J Schwartz IL Prolonged Responses by the Rat Uterus in Vivo to Deamino-Oxytocin Disproportionate to Its Estimated Plasma Half-Life* Endocrinology 1980 106 3 805 810 7353543
Not checked in the free run.
- cites [160] du Vigneaud V Winestock G Murti VVS Hope DB Kimbrough RD Synthesis of 1-β-mercaptopropionic acid oxytocin (desamino-oxytocin), a highly potent analogue of oxytocin J Biol Chem 1960 235 12 PC64 PC66 13724538
Not checked in the free run.
- cites [161] Tyagi MG Murugan MS Influence of Demoxytocin on the Behavioural Actions of Melatonin J Exp Sci 2011 2 8 07 09
Not checked in the free run.
- cites [162] Ulstein M Sagen N Eikhom SN A comparative study of labor induced by oral prostaglandin E2 and buccal tablets of demoxytocin Int J Gynaecol Obstet 1978 17 3 243 245 42577
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationV1 receptors are found on vascular smooth muscle cells, V2 receptors are found in the kidneys, and V3 receptors are found in the pituitary gland.
“V1 receptors are found on vascular smooth muscles cells while V2 receptors are found in the kidneys, and V3 receptors are found in the pituitary gland.[174]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Sharman A Low J Vasopressin and its role in critical care Contin Educ Anaesth Crit Care Pain 2008 8 4 134 137
Not checked in the free run.
May combine two claims.
InterpretationcitationThe C-terminal region of oxytocin is involved in receptor specificity, thus synthetic analogs are usually designed without major truncations of the tail.
“In addition, it was determined that the C-terminal region is involved in receptor specificity, thus synthetic analogs are usually designed without major truncations of the tail.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenProvasopressin folds into its correct structure, including formation of eight disulfide bridges (seven in neurophysin II and one in vasopressin), in the ER.
“Just like prooxytocin, provasopressin folds into its correct structure, including the formation of eight disulfide bridges (seven in neurophysin II and one in vasopressin), in the ER.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenVasopressin, also known as antidiuretic hormone, is a neurohypophysial hormone that differs from oxytocin by two amino acids.
“Vasopressin, also known as antidiuretic hormone, is a neurohypophysial hormone that differs from oxytocin by two amino acids (Figure 9).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVasopressin can also bind to oxytocin receptors with an equal affinity as oxytocin and induce uterine contractions.
“Vasopressin can also bind to oxytocin receptors with an equal affinity as oxytocin and induce uterine contractions.[174, 175]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [174] Sharman A Low J Vasopressin and its role in critical care Contin Educ Anaesth Crit Care Pain 2008 8 4 134 137
Not checked in the free run.
- cites [175] Chan WY Wo NC Manning M The role of oxytocin receptors and vasopressin V 1a receptors in uterine contractions in rats: Implications for tocolytic therapy with oxytocin antagonists Am J Obstet Gynecol 1996 175 5 1331 1335 8942510
Not checked in the free run.
May combine two claims.
PremisecitationThe deamination of Cys at position 1 was found to increase its solubility in lipids, which increased its antidiuretic effect and duration of action, while the substitution with D-Arg diminished its affinity towards the V1 receptor reducing its vasoconstriction abilities.
“The deamination of Cys at position 1 was found to increase its solubility in lipids, which increased its antidiuretic effect and duration of action while the substitution with D-Arg diminished its affinity towards the V1 receptor reducing its vasoconstriction abilities.[189]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [189] Cvetković RS Plosker GL Desmopressin Drugs 2005 65 1 99 107 15610055
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDesmopressin was developed in the mid 1960s and was originally used to treat diabetes insipidus.
“Desmopressin was developed in the mid 1960’s and was originally used to treat diabetes insipidus.[183–187]”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [183] Ślusarz MJ Ślusarz R Ciarkowski J Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist-bound state in the membrane–aqueous system Biopolymers 2006 81 5 321 338 16333859
Not checked in the free run.
- cites [184] Mannucci PM Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years Blood 1997 90 7 2515 2521 9326215
Not checked in the free run.
- cites [185] Becker DJ Foley TP 1-Deamino-8-d-arginine vasopressin in the treatment of central diabetes insipidus in childhood J Pediatr 1978 92 6 1011 1015 660339
Not checked in the free run.
- cites [186] Seif SM Zenser TV Ciarochi FF Davis BB Robinson AG DDAVP (l-Desamino-8-D-arginine-vasopressin) Treatment of Central Diabetes Insipidus—Mechanism of Prolonged Antidiuresis J Clin Endocrinol Metab 1978 46 3 381 388 221517
Not checked in the free run.
- cites [187] Delin K Aurell M Ewald J Urinary concentration test with desmopressin Br Med J 1978 1 6115 757 758 630334 PMC1603301
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFelypressin (Octapressin) is a synthetic vasopressin analog that was developed in 1960 and exhibited a localized vasoconstriction effect.
“Felypressin (Octapressin) is a synthetic vasopressin analog that was developed in 1960 and exhibited a localized vasoconstriction effect.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [179] Åkerman B On Felypressin (Octapressin®) as an Adjunct to Lidocaine and Prilocaine – an Experimental Study in Animals Acta Pharmacol Tox 1966 24 4 377 388 6013120
Not checked in the free run.
- cites [180] Inagawa M Ichinohe T Kaneko Y Felypressin, but not epinephrine, reduces myocardial oxygen tension after an injection of dental local anesthetic solution at routine doses J Oral Maxillofac Surg 2010 68 5 1013 1017 20031290
Not checked in the free run.
- cites [181] Cecanho R De Luca LA Jr Ranali J Anesth Prog Anesthesia progress 2006 53 4 119 125 17177590 PMC1705833
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningThe widespread utilization of cyclic peptides by nature emphasizes the pharmacological advantages of these privileged scaffolds and highlights their therapeutic potential.
“The widespread utilization of cyclic peptides by nature emphasizes the pharmacological advantages of these privileged scaffolds and highlights their therapeutic potential.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenIn bacterial pathogens, such as staphylococcus, enterococcus, and clostridium species, cyclic peptides have the potential to be applied as novel therapeutics aimed to inhibit non-essential pathways responsible for virulence and pathogenicity.
“In the case of bacterial pathogens, such as staphylococcus, enterococcus, and clostridium species, these cyclic peptides have the potential to be applied as novel therapeutics aimed to inhibit non-essential pathways responsible for virulence and pathogenicity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDesmopressin has a longer half-life of around 55 minutes and is very similar to vasopressin except that it has a deaminated N-terminus, along with a D-Arg at position 8.
“Desmopressin has a longer half-life of around 55 minutes and is very similar to vasopressin except that it has a deaminated N-terminus, along with a D-Arg at position 8 (Figure 13).[188]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [188] Vilhardt H Basic pharmacology of desmopressin Drug Invest 1990 2 5 2 8
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenIn symbiotic species, such as lactobacillus, cyclic peptides can be used to enhance the beneficial activity of commensal, quorum-sensing utilizing species.
“In symbiotic species, such as lactobacillus, these peptides can be used to enhance the beneficial activity of commensal, QS utilizing, species.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenCyclic peptide scaffolds are widely used as key components in essential and non-essential signal transduction pathways found in both prokaryotic and eukaryotic organisms.
“Cyclic peptide scaffolds are widely used as key components in essential and non-essential signal transduction pathways found in both prokaryotic and eukaryotic organisms.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDesmopressin is a synthetic analog selective to V2 receptors, which enables its use to retain water in patients without exerting a vasoconstriction effect.
“Desmopressin, another synthetic analog designed to treat specific diseases, is selective to V2 receptors, which enables its use to retain water in patients without exerting a vasoconstriction effect.[182, 183]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [182] Kaufmann JE Iezzi M Vischer UM Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor-and cAMP-mediated signaling J Thromb Haemost 2003 1 4 821 828 12871421
Not checked in the free run.
- cites [183] Ślusarz MJ Ślusarz R Ciarkowski J Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist-bound state in the membrane–aqueous system Biopolymers 2006 81 5 321 338 16333859
Not checked in the free run.
May combine two claims.
PremisecitationSelepressin is a recent analog currently in phase 2 clinical trials and shows great potential as a therapeutic for treating septic shock.
“Selepressin, a recent analog currently in phase 2 clinical trials, shows great potential as a therapeutic for treating septic shock.[194, 195]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [194] He X Su F Taccone FS Laporte R Kjølbye AL Zhang J Xie K Moussa MD Reinheimer TM Vincent J-L A selective v1a receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock Crit Care Med 2016 44 1 23 26496451 PMC4684247
Not checked in the free run.
- cites [195] Asfar P Russell JA Tuckermann J Radermacher P Selepressin in Septic Shock: A Step Toward Decatecholaminization? Crit Care Med 2016 44 1 234 236 26672929
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningMore research in exploiting vasopressin receptors through the development of selective analogs could possibly lead to better treatment options for diseases associated with water retention, bleeding disorders, in addition to social illnesses related to stress, memory, and anxiety.
“More research in exploiting these receptors through the development of selective analogs could possibly lead to better treatment options for diseases associated with water retention, bleeding disorders, in addition to social illnesses related to stress, memory, and anxiety.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTerlipressin is not approved for use in the U.S., but is used in other countries.
“Terlipressin is not approved for use in the U.S, but is used in other countries.[193]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [193] Sharma P Kumar A Shrama BC Sarin SK An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response Am J Gastroenterol 2008 103 7 1689 1697 18557715
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenTerlipressin differs from vasopressin by the addition of three Gly residues at the N-terminus prior to the conserved Cys that occupies the first position in vasopressin, making it an 11-amino acid analog, and contains an Arg to Lys substitution in the eighth position of vasopressin (11th position in Terlipressin).
“This analog differs from vasopressin by the addition of three Gly residues at the N-terminus prior to the conserved Cys that occupies the first position in vasopressin, making this an 11-amino acid analog. In addition, Terlipressin contains an Arg to Lys substitution in the eighth position of vasopressin (11th position in Terlipressin; Figure 13).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTerlipressin is commonly used to treat septic shock, hepatorenal syndrome (kidney failure from cirrhosis), and esophageal varices.
“Terlipressin is commonly used to treat septic shock, hepatorenal syndrome (kidney failure from cirrhosis), and esophageal varices.[190–192]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [190] Solanki P Chawla A Garg R Gupta R Jain M Sarin SK Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo-controlled clinical trial J Gastroenterol Hepatol 2003 18 2 152 156 12542598
Not checked in the free run.
- cites [191] Albanèse J Leone M Delmas A Martin C Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study Crit Care Med 2005 33 9 1897 1902 16148457
Not checked in the free run.
- cites [192] Ioannou GN Doust J Rockey DC Terlipressin in acute oesophageal variceal haemorrhage Aliment Pharm Therap 2003 17 1 53 64 12492732
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenThe modification of cyclic peptides in eukaryotic systems has been shown to result in increased half-life of important hormones and enhanced receptor binding affinities, creating drugs that are longer lasting and faster acting than their parent signals.
“The modification of cyclic peptides in eukaryotic systems has been shown to result in increased half-life of important hormones and enhanced receptor binding affinities, creating drugs that are longer lasting and faster acting than their parent signals.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningMany vasopressin analogs have been synthesized but only a limited number are used therapeutically, demonstrating the need to develop more therapeutically-relevant analogs given that there are three vasopressin subtype receptors that have different functions and distribution in the body.
“Many analogs have been synthesized but only a limited number of analogs are used therapeutically, demonstrating the need to develop more therapeutically-relevant analogs given that there are three vasopressin subtype receptors that have different functions and distribution in the body.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Prokaryotic cyclic peptide signaling pathways, such as quorum sensing, are non-essential.
“In prokaryotic organisms these peptides are utilized in non-essential pathways, such as quorum sensing, that are responsible for virulence and pathogenicity.”
The paper relies on this without support.
Therapeutic modulation of quorum sensing pathways is not likely to pressure bacteria to develop resistance.
“as therapeutic agents that are not likely to pressure the bacteria to develop resistance.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Four fundamental regions in the genome of L. plantarum 55A were identified to produce bacteriocins and secondary metabolites including cyclic-lactone autoinducer, RiPP-like molecules, T3PKS, and terpenes.
“Four fundamental regions in the genome of L. plantarum 55A were identified to produce bacteriocins and secondary metabolites including cyclic-lactone autoinducer”
From Genomic Characterization of Lactiplantibacillus plantarum Strains: Potential Probiotics from Ethiopian Traditional Fermented Cottage Cheese (2024) · cites this paper as [47]
The Introduction’s §1.4 (Lactobacillus; page unavailable) describes L. plantarum producing a cyclic thiolactone autoinducer through its four-gene lam module. It does not identify four genomic regions in strain 55A or report bacteriocins, RiPP-like molecules, T3PKS, or terpenes; its signal is a thiolactone, not a lactone. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Terlipressin amino-acid count is one short
MinorThe paper describes vasopressin as a nine-amino-acid neurohypophysial hormone. Adding three Gly residues would make terlipressin a 12-amino-acid analog, not an 11-amino-acid analog.
Reported 11 · recomputed 12
“This analog differs from vasopressin by the addition of three Gly residues at the N-terminus prior to the conserved Cys that occupies the first position in vasopressin, making this an 11-amino acid analog.”
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,018 · see citing works
Miller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,127 · see citing works
QUORUM SENSING: Cell-to-Cell Communication in Bacteria
Waters, C. M., & Bassler, B. L. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.012704.131001 · Cited by 3,989 · see citing works
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · see citing works
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718 · see citing works
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776 · see citing works
Bacterial Quorum-Sensing Network Architectures
Ng, W., & Bassler, B. L. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134304 · Cited by 1,686 · see citing works
Somatostatin and Its Receptor Family
Patel, Y. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648 · see citing works
Complete genome sequence of <i>Lactobacillus plantarum</i> WCFS1
Kleerebezem, M., Boekhorst, J., van Kranenburg, R., Molenaar, D., Kuipers, O. P., Leer, R., Tarchini, R., Peters, S. A., Sandbrink, H. M., Fiers, M. W. E. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337704100 · Cited by 1,472 · see citing works
Clostridium difficile Infection
Leffler, D. A., & LaMont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,461 · see citing works
Regulation of Gene Expression by Cell-to-Cell Communication: Acyl-Homoserine Lactone Quorum Sensing
Fuqua, C., Parsek, M. R., & Greenberg, E. P. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.090913 · Cited by 1,393 · see citing works
Vancomycin-Resistant Enterococci
Cetinkaya, Y. S., Falk, P. S., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686-707.2000 · Cited by 1,187 · see citing works
Sociomicrobiology: the connections between quorum sensing and biofilms
Parsek, M. R., & Greenberg, E. P. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.007 · Cited by 1,175 · see citing works
Jarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., Nesme, X., Étienne, J., & Vandenesch, F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.631-641.2002 · Cited by 1,147 · see citing works
Probiotics: an overview of beneficial effects
Ouwehand, A. C., Salminen, S., & Isolauri, E. (2002) · Antonie van Leeuwenhoek · doi:10.1023/a:1020620607611 · Cited by 1,045 · see citing works
How bacteria talk to each other: regulation of gene expression by quorum sensing
Bassler, B. L. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00025-9 · Cited by 1,034 · see citing works
Lamberts, S. W. J., van der Lely, A. J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 996 · see citing works
Structural identification of autoinducer of Photobacterium fischeri luciferase
Eberhard, A., Burlingame, A. L., Eberhard, C., Kenyon, G. L., Nealson, K. H., & Oppenheimer, N. J. (1981) · Biochemistry · doi:10.1021/bi00512a013 · Cited by 985 · see citing works
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889 · see citing works
Insulin Degradation: Progress and Potential
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 875 · see citing works
Bacterial Interference Caused by Autoinducing Peptide Variants
Ji, G., Beavis, R. C., & Novick, R. P. (1997) · Science · doi:10.1126/science.276.5321.2027 · Cited by 808 · see citing works
Intrinsic and acquired resistance mechanisms in enterococcus
Hollenbeck, B. L., & Rice, L. B. (2012) · Virulence · doi:10.4161/viru.21282 · Cited by 795 · see citing works
Kleerebezem, M., Quadri, L. E. N., Kuipers, O. P., & de Vos, W. M. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4251782.x · Cited by 791 · see citing works
Protein–protein interactions define specificity in signal transductionPreprint
Pawson, T. J., & Nash, P. (2000) · Genes & Development · doi:10.1101/gad.14.9.1027 · Cited by 775 · see citing works
Complete genome sequence of Clostridium perfringens , an anaerobic flesh-eater
Shimizu, T., Ohtani, K., Hirakawa, H., Ohshima, K., Yamashita, A., Shiba, T., Ogasawara, N., Hattori, M., Kuhara, S., & Hayashi, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022493799 · Cited by 726 · see citing works
Staphylococcus epidermidis infections
Vuong, C., & Otto, M. J. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01563-0 · Cited by 710 · see citing works
Quorum Sensing and Bacterial Social Interactions in Biofilms
Li, Y.-H., & Tian, X. (2012) · Sensors · doi:10.3390/s120302519 · Cited by 706 · see citing works
Bacterial bioluminescence: its control and ecological significance
Nealson, K. H., & Hastings, J. W. (1979) · Microbiological Reviews · doi:10.1128/mr.43.4.496-518.1979 · Cited by 688 · see citing works
Cell density control of staphylococcal virulence mediated by an octapeptide pheromone.
Ji, G., Beavis, R. C., & Novick, R. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12055 · Cited by 658 · see citing works
Regulation of exoprotein gene expression in Staphylococcus aureus by agr
Recsei, P. A., Kreiswirth, B. N., O’Reilly, M., Schlievert, P. M., Gruss, A., & Novick, R. P. (1986) · Molecular and General Genetics MGG · doi:10.1007/bf00330517 · Cited by 619 · see citing works
The Translocon: A Dynamic Gateway at the ER Membrane
Johnson, A. E., & van Waes, M. A. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.799 · Cited by 601 · see citing works
Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
Fu, Z., Gilbert, E. R., & Liu, D. (2013) · PubMed · Cited by 600 · see citing works
Wintermantel, T. M., Campbell, R. E., Porteous, R. W., Bock, D., Gröne, H., Todman, M. G., Korach, K. S., Greiner, E. F., Pérez, C. A., Schütz, G., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.023 · Cited by 598 · see citing works
Peng, H., Novick, R. P., Kreiswirth, B. N., Kornblum, J. S., & Schlievert, P. M. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4365-4372.1988 · Cited by 566 · see citing works
Somatostatin Cell Processes as Pathways for Paracrine Secretion
Larsson, L., Goltermann, N., de Magistris, L., Rehfeld, J. F., & Schwartz, T. W. (1979) · Science · doi:10.1126/science.382360 · Cited by 498 · see citing works
Modulating social behavior with oxytocin: How does it work? What does it mean?
Churchland, P. S., & Winkielman, P. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.003 · Cited by 464 · see citing works
Theagr P2 operon: An autocatalytic sensory transduction system inStaphylococcus aureus
Novick, R. P., Projan, S. J., Kornblum, J. S., et al. (1995) · Molecular and General Genetics MGG · doi:10.1007/bf02191645 · Cited by 462 · see citing works
Mayville, P., Ji, G., Beavis, R. C., Yang, H., Goger, M. J., Novick, R. P., & Muir, T. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1218 · Cited by 455 · see citing works
Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
Jonassen, I., Havelund, S., Hoeg-Jensen, T., Steensgaard, D. B., Wahlund, P.-O., & Ribel, U. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0739-z · Cited by 448 · see citing works
The normal Lactobacillus flora of healthy human rectal and oral mucosa
Ahrné, Nobaek, Jeppsson, Adlerberth, Wold, A. E., & Molin (1998) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1998.00480.x · Cited by 439 · see citing works
Peptide Signaling in the Staphylococci
Thoendel, M., Kavanaugh, J. S., Flack, C. E., & Horswill, A. R. (2010) · Chemical Reviews · doi:10.1021/cr100370n · Cited by 437 · see citing works
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · see citing works
A potent cyclic hexapeptide analogue of somatostatin
Veber, D. F., Freidinger, R. M., Perlow, D. S., et al. (1981) · Nature · doi:10.1038/292055a0 · Cited by 418 · see citing works
Clostridium difficile Infection
Kelly, C. P., & LaMont, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.375 · Cited by 413 · see citing works
Molecular genetics and pathogenesis of Clostridium perfringens
Rood, J. I., & Cole, S. T. (1991) · Microbiological Reviews · doi:10.1128/mr.55.4.621-648.1991 · Cited by 406 · see citing works
Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
Mannucci, P. M. (1997) · Blood · doi:10.1182/blood.v90.7.2515.2515_2515_2521 · Cited by 398 · see citing works
Cyclic Peptides as Therapeutic Agents and Biochemical Tools
Joo, S. H. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.1.019 · Cited by 359 · see citing works
Visick, K. L., Foster, J. S., Doino, J., McFall‐Ngai, M., & Ruby, E. G. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.16.4578-4586.2000 · Cited by 357 · see citing works
Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.
(2003) · Critical Care · doi:10.1186/cc2337 · Cited by 356 · see citing works
Insulin analogues and their potential in the management of diabetes mellitus
Bolli, G. B., DiMarchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051286 · Cited by 350 · see citing works
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Burbach, J. P. H., Luckman, S. M., Murphy, D., & Gainer, H. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1197 · Cited by 338 · see citing works
Kurtzhals, P., Havelund, S., Jonassen, I., Kiehr, B., Larsen, U. D., Ribel, U., & Markussen, J. (1995) · Biochemical Journal · doi:10.1042/bj3120725 · Cited by 334 · see citing works
Hancock, L. E., & Perego, M. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.17.5629-5639.2004 · Cited by 314 · see citing works
The magnocellular oxytocin system, the fount of maternity: Adaptations in pregnancy
Russell, J. A., Leng, G., & Douglas, A. J. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/s0091-3022(02)00104-8 · Cited by 295 · see citing works
Vague, P., Selam, J.-L., Skeie, S., De Leeuw, I., Elte, J. W. F., Haahr, H., Kristensen, A., & Draeger, E. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.590 · Cited by 294 · see citing works
Exfoliatin-Producing Strains Define a Fourth agr Specificity Group in Staphylococcus aureus
Jarraud, S., Lyon, G. J., Figueiredo, A. M. S., Lina, G., Vandenesch, F., Étienne, J., Muir, T. W., & Novick, R. P. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.22.6517-6522.2000 · Cited by 292 · see citing works
SOLANKI, P., CHAWLA, A., Garg, R., GUPTA, R., JAIN, M., & Sarin, S. K. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02934.x · Cited by 287 · see citing works
Sharma, P., Kumar, A., Shrama, B. C., & Sarin, S. K. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01828.x · Cited by 277 · see citing works
Enterococcal infections & antimicrobial resistance.
Sood, S., Malhotra, M., Das, B. K., & Kapil, A. (2008) · PubMed · Cited by 273 · see citing works
Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
Harris, A. G. (1994) · Gut · doi:10.1136/gut.35.3_suppl.s1 · Cited by 268 · see citing works
Breaking the loop: Oxytocin as a potential treatment for drug addiction
McGregor, I. S., & Bowen, M. T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.001 · Cited by 268 · see citing works
Lyon, G. J., Mayville, P., Muir, T. W., & Novick, R. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13330 · Cited by 263 · see citing works
Nakayama, J., Cao, Y. H., Horii, T., Sakuda, S., Akkermans, A. D. L., de Vos, W. M., & Nagasawa, H. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02486.x · Cited by 263 · see citing works
Coque, T. M., PATTERSON, J. E., Steckelberg, J. M., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.5.1223 · Cited by 259 · see citing works
Vancomycin‐Resistant Enterococci: Mechanisms and Clinical Observations
Gold, H. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321815 · Cited by 258 · see citing works
Welches, W. R., Brosnihan, K. B., & Ferrario, C. M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90108-f · Cited by 254 · see citing works
A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance
Haahr, H., & Heise, T. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0165-y · Cited by 226 · see citing works
Clonal Distribution of Superantigen Genes in ClinicalStaphylococcus aureusIsolates
Holtfreter, S., Grumann, D., Schmudde, M., Nguyen, H. T. T., Eichler, P., Strommenger, B., Kopron, K., Kolata, J., Giedrys‐Kalemba, S., Steinmetz, I., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00204-07 · Cited by 224 · see citing works
Sifri, C. D., Mylonakis, E. E., Singh, K. V., Qin, X., Garsin, D. A., Murray, B. E., Ausubel, F. M., & Calderwood, S. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5647-5650.2002 · Cited by 222 · see citing works
Fear-enhancing effects of septal oxytocin receptors
Guzmán, Y. F., Tronson, N. C., Jovasevic, V., Sato, K., Guedea, A. L., Mizukami, H., Nishimori, K., & Radulovic, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3465 · Cited by 215 · see citing works
High Genetic Variability of the agr Locus in Staphylococcus Species
Dufour, P., Jarraud, S., Vandenesch, F., Greenland, T., Novick, R. P., Bes, M., Étienne, J., & Lina, G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1180-1186.2002 · Cited by 213 · see citing works
Key Determinants of Receptor Activation in the agr Autoinducing Peptides of Staphylococcus aureus
Lyon, G. J., Wright, J. S., Muir, T. W., et al. (2002) · Biochemistry · doi:10.1021/bi026049u · Cited by 213 · see citing works
Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study*
Albanèse, J., Léone, M., Delmas, A., & Martin, C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178182.37639.d6 · Cited by 211 · see citing works
Janzon, L., Löfdahl, S., & Arvidson, S. (1989) · Molecular and General Genetics MGG · doi:10.1007/bf00259623 · Cited by 207 · see citing works
Pheromone Cross-Inhibition between Staphylococcus aureus and Staphylococcus epidermidis
Otto, M. J., Echner, H., Voelter, W., & Götz, F. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1957-1960.2001 · Cited by 202 · see citing works
Choi, S. H., & Greenberg, E. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11115 · Cited by 201 · see citing works
MDowell, P., Affas, Z., Reynolds, C., Holden, M. T. G., Wood, S. J., Saint, S., Cockayne, A., Hill, P. J., Dodd, C. E. R., Bycroft, B. W., et al. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02539.x · Cited by 190 · see citing works
Terlipressin in acute oesophageal variceal haemorrhage
Ioannou, G. N., Doust, J. A., & Rockey, D. C. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01356.x · Cited by 185 · see citing works
Hambleton, P. (1992) · Journal of Neurology · doi:10.1007/bf00839205 · Cited by 177 · see citing works
Otto, M. J., Süßmuth, R. D., Vuong, C., Jung, G., & Götz, F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00514-1 · Cited by 171 · see citing works
Holleman, F., & Hoekstra, J. B. L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370307 · Cited by 169 · see citing works
Therapeutic uses of somatostatin and its analogues: Current view and potential applications
Rai, U., Thrimawithana, T. R., Valéry, C., & Young, S. A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.007 · Cited by 168 · see citing works
A super active cyclic hexapeptide analog of somatostatin
Veber, D. F., Saperstein, R., Nutt, R. F., Freidinger, R. M., Brady, S. F., Curley, P., Perlow, D. S., Paleveda, W. J., COLTON, C. D., Zacchei, A. G., et al. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90009-2 · Cited by 165 · see citing works
Attenuating Staphylococcus aureus Virulence Gene Regulation: A Medicinal Chemistry Perspective
Gordon, C. P., Williams, P. M., & Chan, W. C. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3014635 · Cited by 164 · see citing works
Structure of the pheromone peptide of the Staphylococcus epidermidis agr system
Otto, M. J., Süßmuth, R. D., Jung, G., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00145-8 · Cited by 160 · see citing works
Flexible Or Fixed: A Comparative Review Of Linear And Cyclic Cancer-Targeting Peptides
Roxin, Á., & Zheng, G. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.75 · Cited by 158 · see citing works
Sturme, M. H. J., Nakayama, J., Douwe Molenaar, B., Murakami, Y., Kunugi, R., Fujii, T., Vaughan, E. E., Kleerebezem, M., & de Vos, W. M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5224-5235.2005 · Cited by 156 · see citing works
Anagnostou, E., Soorya, L., Brian, J., Dupuis, A., Mankad, D., Smile, S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.049 · Cited by 155 · see citing works
Catt, K. J., & Dufau, M. L. (1977) · Annual Review of Physiology · doi:10.1146/annurev.ph.39.030177.002525 · Cited by 151 · see citing works
Tal‐Gan, Y., Stacy, D. M., Foegen, M. K., Koenig, D. W., & Blackwell, H. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3112115 · Cited by 139 · see citing works
Self-citationSomatostatin and somatostatin receptors in the immune system: a review.
ten Bokum, A., Hofland, L. J., & van Hagen, P. M. (2000) · PubMed · Cited by 138 · see citing works
George, E. A., Novick, R. P., & Muir, T. W. (2008) · Journal of the American Chemical Society · doi:10.1021/ja711126e · Cited by 134 · see citing works
Evolution of cyclic peptide protease inhibitors
Young, T. S., Young, D. D., Ahmad, I., Louis, J. M., Benkovic, S. J., & Schultz, P. G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108045108 · Cited by 128 · see citing works
Olson, M. E., Todd, D. A., Schaeffer, C. R., Paharik, A. E., Dyke, M. J. V., Büttner, H., Dunman, P. M., Rohde, H., Cech, N. B., Fey, P. D., et al. (2014) · Journal of Bacteriology · doi:10.1128/jb.01882-14 · Cited by 125 · see citing works
Limbago, B. M., Fosheim, G. E., Schoonover, V., Crane, C. E., Nadle, J., Petit, S., Heltzel, D., Ray, S. M., Harrison, L. H., Lynfield, R., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02264-08 · Cited by 124 · see citing works
Cooksley, C. M., Davis, I. J., Winzer, K., Chan, W. C., Peck, M. W., & Minton, N. P. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.03038-09 · Cited by 122 · see citing works
Vidal, J. E., Chen, J., Li, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006232 · Cited by 122 · see citing works
Gerdt, J. P., & Blackwell, H. E. (2014) · ACS Chemical Biology · doi:10.1021/cb5004288 · Cited by 118 · see citing works
Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.
Homko, C., Deluzio, A., Jimenez, C. C., Kolaczynski, J., & Boden, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2027 · Cited by 118 · see citing works
Nakayama, J., Chen, S., Oyama, N., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.00865-06 · Cited by 117 · see citing works
Xu, H., & Shields, D. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.6.1169 · Cited by 117 · see citing works
Kurtzhals, P. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802746 · Cited by 116 · see citing works
Vasopressin Analogs That Antagonize Antidiuretic Responses by Rats to the Antidiuretic Hormone
Sawyer, W. H., Pang, P. K. T., SETO, J., McEnroe, M., Lammek, B., & Manning, M. (1981) · Science · doi:10.1126/science.7209515 · Cited by 115 · see citing works
Li, J., Chen, J., Vidal, J. E., & McClane, B. A. (2011) · Infection and Immunity · doi:10.1128/iai.00169-11 · Cited by 115 · see citing works
Chan, W. C., Coyle, B. J., & Williams, P. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0400754 · Cited by 112 · see citing works
Nonsocial Functions of Hypothalamic Oxytocin
Yang, H.-P., Wang, L., Han, L., & Wang, S. C. (2013) · ISRN Neuroscience · doi:10.1155/2013/179272 · Cited by 111 · see citing works
Fabian, M., Forsling, M. L., Jones, J. J., & Pryor, J. S. (1969) · The Journal of Physiology · doi:10.1113/jphysiol.1969.sp008937 · Cited by 107 · see citing works
agr receptor mutants reveal distinct modes of inhibition by staphylococcal autoinducing peptides
Geisinger, E., Muir, T. W., & Novick, R. P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807760106 · Cited by 107 · see citing works
Identification of Staphylococcus aureus AgrD Residues Required for Autoinducing Peptide Biosynthesis
Thoendel, M., & Horswill, A. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031757 · Cited by 98 · see citing works
Steiner, E., Scott, J., Minton, N. P., et al. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.06376-11 · Cited by 96 · see citing works
Wright, J. S., Lyon, G. J., George, E. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404039101 · Cited by 95 · see citing works
Rotondo, F., Butz, H., Syro, L. V., Yousef, G. M., Di Ieva, A., Restrepo, L. M., Quintanar-Stephano, A., Berczi, I., & Kovacs, K. (2016) · Pituitary · doi:10.1007/s11102-015-0703-0 · Cited by 93 · see citing works
Oxytocin receptors: ligand binding, signalling and cholesterol dependence
Gimpl, G., Reitz, J., Brauer, S., & TROSSEN, C. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00417-2 · Cited by 92 · see citing works
Geisinger, E., George, E. A., Muir, T. W., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710227200 · Cited by 92 · see citing works
Reversible and Specific Extracellular Antagonism of Receptor-Histidine Kinase Signaling
Lyon, G. J., Wright, J. S., Christopoulos, A., Novick, R. P., & Muir, T. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109989200 · Cited by 91 · see citing works
Borruto, F., Treisser, A., & Comparetto, C. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-0973-8 · Cited by 88 · see citing works
Mentlein, R., & Dahms, P. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010027.x · Cited by 87 · see citing works
Hess, S., Linde, Y., Ovadia, O., Safrai, E., Shalev, D. E., Swed, A., Halbfinger, E., Lapidot, T., Winkler, I., Gabinet, Y., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701093y · Cited by 86 · see citing works
Hess, S., Ovadia, O., Shalev, D. E., Senderovich, H., Qadri, B., Yehezkel, T., Salitra, Y., Sheynis, T., Jelinek, R., Gilon, C., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070836d · Cited by 86 · see citing works
du Vigneaud, V., Winestock, G., Murti, V. V. S., et al. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64530-2 · Cited by 85 · see citing works
Making sense of quorum sensing in lactobacilli: a special focus on Lactobacillus plantarum WCFS1
Sturme, M. H. J., Francke, C., Siezen, R. J., de Vos, W. M., & Kleerebezem, M. (2007) · Microbiology · doi:10.1099/mic.0.2007/012831-0 · Cited by 85 · see citing works
Klonoff, D. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814555820 · Cited by 85 · see citing works
Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review
Heringa, S. M., Begemann, M., Goverde, A. J., & Sommer, I. E. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.002 · Cited by 82 · see citing works
Engstrøm, T., Barth, T., Melin, P., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00513-5 · Cited by 80 · see citing works
Vasopressin and its antagonists: what are their roles in acute medical care?
Mitchell, S. L. M., & Hunter, J. M. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem204 · Cited by 79 · see citing works
Identification of a two-component VirR/VirS regulon in Clostridium perfringens
Ohtani, K., Hirakawa, H., Tashiro, K., et al. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.10.003 · Cited by 78 · see citing works
Saenz, H., Augsburger, V., Vuong, C., Jack, R. W., Götz, F., & Otto, M. J. (2000) · Archives of Microbiology · doi:10.1007/s002030000223 · Cited by 78 · see citing works
Kaufmann, J. E., Iezzi, M., & Vischer, U. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00197.x · Cited by 75 · see citing works
He, X., Su, F., Taccone, F. S., Laporte, R., Kjølbye, A. L., Zhang, J., Xie, K., Moussa, M. D., Reinheimer, T. M., & Vincent, J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001380 · Cited by 75 · see citing works
Tal‐Gan, Y., Ivancic, M., Cornilescu, G., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602974 · Cited by 73 · see citing works
Self-citationPatel, Y., & O'Neil, W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)35416-x · Cited by 72 · see citing works
Lee, A. S. Y., & Song, K. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.131 · Cited by 71 · see citing works
SEIF, S. M., Zenser, T. V., Ciarochi, F. F., Davis, B. B., & ROBINSON, A. G. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-3-381 · Cited by 69 · see citing works
Dynamic Processing of Neuropeptides
Acher, R., Chauvet, J., & Rouillé, Y. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:3:223 · Cited by 65 · see citing works
Vidal, J. E., Ma, M., Saputo, J., et al. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07925.x · Cited by 62 · see citing works
Template-constrained macrocyclic peptides prepared from native, unprotected precursors
Lawson, K. V., Rose, T. E., & Harran, P. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311706110 · Cited by 60 · see citing works
Selection-based discovery of macrocyclic peptides for the next generation therapeutics
Morioka, T., Loik, N. D., Hipolito, C. J., et al. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.01.023 · Cited by 59 · see citing works
Tal‐Gan, Y., Ivancic, M., Cornilescu, G., Cornilescu, C. C., & Blackwell, H. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja407533e · Cited by 58 · see citing works
Self-citationWang, B., Zhao, A., Novick, R. P., & Muir, T. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506030112 · Cited by 58 · see citing works
Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response.
Evans, J. H., & Meadow, S. R. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.2.184 · Cited by 57 · see citing works
Sun, L., & Coy, D. H. (2014) · Current Drug Targets · doi:10.2174/1389450116666141205163548 · Cited by 57 · see citing works
Yang, T., Tal‐Gan, Y., Paharik, A. E., Horswill, A. R., & Blackwell, H. E. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00120 · Cited by 56 · see citing works
Self-citationKratochvil, M. J., Tal‐Gan, Y., Yang, T., Blackwell, H. E., & Lynn, D. M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00313 · Cited by 54 · see citing works
Self-citationJi, G., Pei, W., Zhang, L., et al. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.9.3139-3150.2005 · Cited by 53 · see citing works
Development of a Peptide Antagonist against fsr Quorum Sensing of Enterococcus faecalis
Nakayama, J., Yokohata, R., Sato, M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb300717f · Cited by 52 · see citing works
Tal‐Gan, Y., Ivancic, M., Cornilescu, G., & Blackwell, H. E. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01735a · Cited by 50 · see citing works
Self-citationMolecular events in expression of vasopressin and oxytocin and their cognate receptors
Richter, D. (1988) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1988.255.2.f207 · Cited by 50 · see citing works
Side-chain-to-tail thiolactone peptide inhibitors of the staphylococcal quorum-sensing system
Scott, R. J., Lian, L.-Y., Muharram, S. H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00497-9 · Cited by 49 · see citing works
Chen, J., & McClane, B. A. (2012) · Infection and Immunity · doi:10.1128/iai.00438-12 · Cited by 49 · see citing works
Octreotide Long-Acting Release (LAR)
McKeage, K., Cheer, S., & Wagstaff, A. (2012) · Drugs · doi:10.2165/00003495-200363220-00014 · Cited by 47 · see citing works
Nakayama, J., Yong, C. A. O., Horii, T., et al. (2001) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.65.2322 · Cited by 47 · see citing works
1-Deamino-8-d-arginine vasopressin in the treatment of central diabetes insipidus in childhood
Becker, D. J., & Foley, T. P. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80389-8 · Cited by 44 · see citing works
Cvetkovi, R. S., & Plosker, G. L. (2005) · Drugs · doi:10.2165/00003495-200565010-00008 · Cited by 43 · see citing works
Goerke, C., Kümmel, M., Dietz, K., & Wolz, C. (2003) · The Journal of Infectious Diseases · doi:10.1086/376450 · Cited by 42 · see citing works
Newer insulin analogs: advances in basal insulin replacement
Zinman, B. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12068 · Cited by 37 · see citing works
Gimpl, G., Postina, R., Fahrenholz, F., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.010 · Cited by 37 · see citing works
Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2
Joo, K. W., Jeon, U. S., Kim, G., Park, J., Oh, Y. K., Kim, Y. S., Ahn, C., Kim, S., Kim, S. Y., Lee, J. S., et al. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh413 · Cited by 37 · see citing works
New, Potent, and Selective Peptidic Oxytocin Receptor Agonists
Wiśniewski, K., Alagarsamy, S., Galyean, R., Tariga, H., Thompson, D., Ly, B., Wiśniewska, H., Qi, S., Croston, G. E., Laporte, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500365s · Cited by 37 · see citing works
Nishiguchi, K., Nagata, K., Tanokura, M., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.01029-08 · Cited by 36 · see citing works
Increasing AIP Macrocycle Size Reveals Key Features of agr Activation in Staphylococcus aureus
Johnson, J., Wang, B., Debelouchina, G. T., et al. (2015) · ChemBioChem · doi:10.1002/cbic.201500006 · Cited by 35 · see citing works
Garnock-Jones, K. P., & Plosker, G. L. (2009) · Drugs · doi:10.2165/00003495-200969080-00006 · Cited by 35 · see citing works
Broderick, A. H., Stacy, D. M., Tal‐Gan, Y., Kratochvil, M. J., Blackwell, H. E., & Lynn, D. M. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300119 · Cited by 35 · see citing works
Self-citationSCHRAMME, A. R., Pinto, C. R. F., Davis, J. L., et al. (2008) · Equine Veterinary Journal · doi:10.2746/042516408x334343 · Cited by 34 · see citing works
Ma, M., Li, J., & McClane, B. A. (2015) · Journal of Bacteriology · doi:10.1128/jb.02614-14 · Cited by 34 · see citing works
Anticonvulsant neuropeptides as drug leads for neurological diseases
Robertson, C. R., Flynn, S. P., White, H. S., & Bulaj, G. W. (2011) · Natural Product Reports · doi:10.1039/c0np00048e · Cited by 33 · see citing works
Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus
Atkin, S. L., Javed, Z., & Fulcher, G. R. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315608646 · Cited by 33 · see citing works
Tal‐Gan, Y., Stacy, D. M., & Blackwell, H. E. (2014) · Chemical Communications · doi:10.1039/c4cc00117f · Cited by 32 · see citing works
Self-citationPherotypes are driving genetic differentiation within Streptococcus pneumoniae
Carrolo, M., Pinto, F. R., Melo‐Cristino, J., & Ramirez, M. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-191 · Cited by 32 · see citing works
Chan, W. Y., Wo, N. C., & Manning, M. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70050-9 · Cited by 31 · see citing works
Shah, P., Rahman, S. A., McElroy, S., Gilbert, C., Morgan, K., Hinchey, L., Senniappan, S., Levy, H., Amin, R., & Hussain, K. (2015) · Hormone Research in Paediatrics · doi:10.1159/000439131 · Cited by 29 · see citing works
Patel, Y., Galanopoulou, A. S., RABBANI, S. N., et al. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00107-x · Cited by 28 · see citing works
Inagawa, M., Ichinohe, T., & Kaneko, Y. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.07.080 · Cited by 27 · see citing works
Urinary concentration test with desmopressin.
Delin, K., Aurell, M., & Ewald, J. (1978) · BMJ · doi:10.1136/bmj.1.6115.757 · Cited by 27 · see citing works
Cardiovascular Effects of Felypressin
Cecanho, R., Junior, L. A. D. L., & Ranali, J. (2006) · Anesthesia Progress · doi:10.2344/0003-3006(2006)53[119:ceof]2.0.co;2 · Cited by 26 · see citing works
Ślusarz, M. J., Ślusarz, R., & Ciarkowski, J. (2005) · Biopolymers · doi:10.1002/bip.20420 · Cited by 25 · see citing works
Asfar, P., Russell, J. A., Tuckermann, J. P., & Radermacher, P. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001441 · Cited by 23 · see citing works
Hodge, E. K., Hughes, D. W., & Attridge, R. L. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016656384 · Cited by 23 · see citing works
Naveh, S., Tal‐Gan, Y., Ling, S., Hoffman, A., Holoshitz, J., & Gilon, C. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.098 · Cited by 18 · see citing works
Self-citationAkerman, B. (1966) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1966.tb00400.x · Cited by 15 · see citing works
Terashima, Y., Kondo, K., & Oiso, Y. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00078-8 · Cited by 15 · see citing works
Prohormone and proneuropeptide synthesis and secretion.
Perone, M. J., & Castro, M. G. (1997) · PubMed · Cited by 15 · see citing works
Evolving Role of Vasopressin in the Treatment of Cardiac Arrest
Miano, T. A., & Crouch, M. A. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.6.828 · Cited by 14 · see citing works
Gazis, D., ROY, J., & Schwartz, I. L. (1980) · Endocrinology · doi:10.1210/endo-106-3-805 · Cited by 9 · see citing works
Interaction of Chymotrypsin with Carbetocin ([1‐deamino‐1‐monocarba‐2‐O‐methyltyrosine]‐oxytocin)
Vilhardt, H., Atke, A., Barthová, J., et al. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00045.x · Cited by 8 · see citing works
A Comparative Study of Labor Induced by Oral Prostaglandin E2 and Buccal Tablets of Demoxytocin
Ulstein, M., Sagen, N., & Eikhom, I. N. (1979) · International Journal of Gynecology & Obstetrics · doi:10.1002/j.1879-3479.1979.tb00158.x · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- [93]Vaughan EE de Vries MC Zoetendal EG Ben-Amor K Akkermans AD de Vos WM In Lactic Acid Bacteria: Genetics, Metabolism and Applications Springer 2002 341 352
- [101]Nussey SS Whitehead SA Endocrinology: an integrated approach CRC Press 2013 20821847
- [105]Blobel G Sabatini DD Biomembranes Springer 1971 193 195
- [108]Cooper GM The Cell: A Molecular Approach 2 ASM Press 2000
- [116]Kumar U Grant M Cellular Peptide Hormone Synthesis and Secretory Pathways Rehfeld FJ Bundgaard RJ Springer Berlin Heidelberg Berlin, Heidelberg 2010 97 120
Cited by
Sorted by citations
Aziz, T., Naveed, M., Sarwar, A., Makhdoom, S. I., Mughal, M. S., Ali, U., Yang, Z., Shahzad, M., Sameeh, M. Y., Alruways, M. W., et al. (2022) · Molecules · doi:10.3390/molecules27175399 · Cited by 53 · see citing works
Gizachew, S., & Engidawork, E. (2024) · Genes · doi:10.3390/genes15111389 · Cited by 15 · see citing works
“…cell density to regulate the production of adhesins used for biofilm formation as well as enzymes involved in the utilization of different sugars) [47], RiPP-like molecules (exhibit antibacterial activity) [48], T3PKS (produce secondary metabolites with diverse biological activities, including…”
- Authors
- Mull, R. W., Harrington, A., Sanchez, L. A., & Tal-Gan, Y.
- Affiliations
- University of Nevada, Reno (US)
- Department of Chemistry, University of Nevada, Reno, NV 89557, United States
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2018-07-09
- Volume
- 18
- Issue
- 7
- Pages
- 625-644
- ISSN
- 1568-0266 (ISSN-L)
- PMC
- PMC6050129
- OpenAlex
- W2803189598
- Semantic Scholar
- 9c1ecfb7ee3c9669da031273317c31784d75535f
- Cited by
- 41
- References
- 185
- Citations by year
- 2026: 7 · 2025: 1 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 3
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Current Topics in Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM103440)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Keywords
- cyclic peptides, signal transduction, quorum sensing, hormonal regulation, receptor activation, therapeutics, virulence
- MeSH terms
- Amino Acid Sequence, Bacteria, Eukaryotic Cells, Peptides, Cyclic, Prokaryotic Cells, Signal Transduction, Quorum Sensing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review